{"DataElement":{"publicId":"14596197","version":"1","preferredName":"Disease Description Name","preferredDefinition":"A description of the disease.","longName":"DS_DSCRPT_NM","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"2013945","version":"1","preferredName":"Disease Description","preferredDefinition":"a description of the patient's cancer.","longName":"DZ_DESC","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2177151","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A disease is any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. Sometimes the term is used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function. (from Wikipedia)","longName":"Disease","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACAAECCE-7A50-657B-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"Updated to add EVS concept preferred name. dw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177536","version":"1","preferredName":"Description ","preferredDefinition":"Description; a statement that represents something in words.","longName":"Description","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-51C1-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B279CABB-9FFB-1FF0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-23","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14596130","version":"1","preferredName":"Disease or Disorder Name","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._The words or language units by which a thing is known.","longName":"14596130v1.00","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Carcinosarcoma of the uterus","valueDescription":null,"ValueMeaning":{"publicId":"3179372","version":"1","preferredName":"Uterine Carcinosarcoma","longName":"3179372","preferredDefinition":"A usually aggressive malignant neoplasm arising from the uterine corpus and less often the cervix.  It is characterized by the presence of two components: a malignant epithelial component and a sarcomatous component.  In the uterine corpus the epithelial component is usually glandular whereas in the cervix is usually non-glandular.  Carcinosarcoma of the cervix, although it is aggressive, it may have a better prognosis compared to the uterine corpus carcinosarcoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Carcinosarcoma","conceptCode":"C42700","definition":"A usually aggressive malignant neoplasm arising from the uterine corpus and less often the cervix.  It is characterized by the presence of two components: a malignant epithelial component and a sarcomatous component.  In the uterine corpus the epithelial component is usually glandular whereas in the cervix is usually non-glandular.  Carcinosarcoma of the cervix, although it is aggressive, it may have a better prognosis compared to the uterine corpus carcinosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-87CE-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092D8E25-EDD3-1984-E063-731AD00A95DE","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"TYRRELLM","dateModified":"2023-11-02","deletedIndicator":"No"},{"value":"Adenocarcinoma of the cervix","valueDescription":null,"ValueMeaning":{"publicId":"4722591","version":"1","preferredName":"Cervical Adenocarcinoma","longName":"4722591","preferredDefinition":"An adenocarcinoma arising from the cervical epithelium. It accounts for approximately 15% of invasive cervical carcinomas. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors. Grossly, advanced cervical adenocarcinoma may present as an exophytic mass, an ulcerated lesion, or diffuse cervical enlargement. Microscopically, the majority of cervical adenocarcinomas are of the endocervical (mucinous) type.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Adenocarcinoma","conceptCode":"C4029","definition":"An adenocarcinoma arising from the endocervical glandular epithelium. It is classified as either human papillomavirus-related or human papillomavirus-independent adenocarcinoma. Histologic variants include usual-type, mucinous, mesonephric, serous, clear cell, and endometrioid adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-BA67-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E4614-8D30-4361-E063-731AD00ABCAB","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"TYRRELLM","dateModified":"2023-11-02","deletedIndicator":"No"},{"value":"Cervical cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"5581330","version":"1","preferredName":"Cervical Carcinoma","longName":"5581330","preferredDefinition":"A carcinoma arising from either the exocervical squamous epithelium or the endocervical glandular epithelium. The major histologic types of cervical carcinoma are: squamous carcinoma, adenocarcinoma, adenosquamous carcinoma, adenoid cystic carcinoma and undifferentiated carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Carcinoma","conceptCode":"C9039","definition":"A carcinoma arising from either the exocervical squamous epithelium or the endocervical glandular epithelium. The major histologic types of cervical carcinoma are squamous cell carcinoma and adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B6F3-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E4614-8D31-4361-E063-731AD00ABCAB","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"TYRRELLM","dateModified":"2023-11-02","deletedIndicator":"No"},{"value":"Endometrioid endometrial adenocarcinoma","valueDescription":null,"ValueMeaning":{"publicId":"3475265","version":"1","preferredName":"Endometrial Endometrioid Adenocarcinoma","longName":"3475265","preferredDefinition":"A primary endometrial adenocarcinoma composed of neoplastic cells that form complex glandular patterns associated with budding and branching of the neoplastic glands.  The neoplastic glands resemble those of the normal endometrium and may or may not be associated with sheet-like proliferation of malignant cells.  Endometrioid adenocarcinoma is the most commonly seen morphologic variant of endometrial adenocarcinoma. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Endometrioid Adenocarcinoma","conceptCode":"C6287","definition":"A primary endometrial adenocarcinoma composed of neoplastic cells that form complex glandular patterns associated with budding and branching of the neoplastic glands.  The neoplastic glands resemble those of the normal endometrium and may or may not be associated with sheet-like proliferation of malignant cells.  Endometrioid adenocarcinoma is the most commonly seen morphologic variant of endometrial adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1D37D29-6B00-D1BD-E040-BB89AD4325DD","latestVersionIndicator":"Yes","beginDate":"2012-06-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-06-06","modifiedBy":"TSESU","dateModified":"2023-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E4614-8D32-4361-E063-731AD00ABCAB","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"TYRRELLM","dateModified":"2023-11-02","deletedIndicator":"No"},{"value":"Fallopian tube carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"3210700","version":"1","preferredName":"Fallopian Tube Carcinoma","longName":"3210700","preferredDefinition":"A carcinoma arising from the fallopian tube which is attached to the uterine corpus (uterine body). Most patients are postmenopausal, and postmenopausal bleeding is the most frequently seen symptom. Morphologically, the majority of fallopian tube carcinomas are serous or endometrioid adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fallopian Tube Carcinoma","conceptCode":"C3867","definition":"A carcinoma arising from the fallopian tube. Most patients are postmenopausal, and postmenopausal bleeding is the most frequently seen symptom. Morphologically, the majority of fallopian tube carcinomas are serous or endometrioid adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9080-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E4614-8D33-4361-E063-731AD00ABCAB","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"TYRRELLM","dateModified":"2023-11-02","deletedIndicator":"No"},{"value":"Female reproductive system cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722593","version":"1","preferredName":"Malignant Female Reproductive System Neoplasm","longName":"4722593","preferredDefinition":"Cancer of the female reproductive tract, including the cervix, endometrium, fallopian tubes, ovaries, uterus, and vagina.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Female Reproductive System Neoplasm","conceptCode":"C4913","definition":"A primary or metastatic malignant neoplasm involving the female reproductive system.  Representative examples include endometrial carcinoma, cervical carcinoma, ovarian carcinoma, uterine corpus leiomyosarcoma, adenosarcoma, malignant mixed mesodermal (mullerian) tumor, and gestational choriocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-BAD7-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E4614-8D34-4361-E063-731AD00ABCAB","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"TYRRELLM","dateModified":"2023-11-02","deletedIndicator":"No"},{"value":"Primary peritoneal carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"4722587","version":"1","preferredName":"Primary Peritoneal Carcinoma","longName":"4722587","preferredDefinition":"A rare carcinoma that arises from the peritoneum and resembles the malignant surface epithelial-stromal tumors that arise from the ovary.  Serous adenocarcinoma is the most common histologic variant. It affects women almost exclusively.  The diagnosis of primary peritoneal carcinoma can be made only if both ovaries are not involved by tumor, or, if the ovaries are involved, the tumor is confined to the ovarian surface without invasion of the ovarian stroma and the peritoneal involvement is greater than the ovarian surface involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Peritoneal Carcinoma","conceptCode":"C40022","definition":"A rare carcinoma that arises from the peritoneum and resembles the malignant surface epithelial-stromal tumors that arise from the ovary.  Serous adenocarcinoma is the most common histologic variant. It affects women almost exclusively.  The diagnosis of primary peritoneal carcinoma can be made only if both ovaries are not involved by tumor, or, if the ovaries are involved, the tumor is confined to the ovarian surface without invasion of the ovarian stroma and the peritoneal involvement is greater than the ovarian surface involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B9DC-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E4614-8D35-4361-E063-731AD00ABCAB","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"TYRRELLM","dateModified":"2023-11-02","deletedIndicator":"No"},{"value":"Solid tumor, NOS","valueDescription":null,"ValueMeaning":{"publicId":"5438011","version":"1","preferredName":"Solid Neoplasm","longName":"5438011","preferredDefinition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas. Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma). Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Solid Neoplasm","conceptCode":"C9292","definition":"A benign or malignant neoplasm arising from tissues that do not include fluid areas.  Representative examples include epithelial neoplasms (e.g. lung carcinoma, prostate carcinoma, breast carcinoma, colon carcinoma), and neoplasms arising from the soft tissues and bones (e.g. leiomyosarcoma, liposarcoma, chondrosarcoma, osteosarcoma).  Neoplasms originating from the blood or bone marrow (leukemias and myeloproliferative disorders) are not considered solid tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3B3C588B-6791-0A60-E050-BB89AD432BC1","latestVersionIndicator":"Yes","beginDate":"2016-08-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E4614-8D36-4361-E063-731AD00ABCAB","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"TYRRELLM","dateModified":"2023-11-02","deletedIndicator":"No"},{"value":"Ovarian epithelial cancer","valueDescription":null,"ValueMeaning":{"publicId":"2593147","version":"1","preferredName":"Ovarian Carcinoma","longName":"2593147","preferredDefinition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Carcinoma","conceptCode":"C4908","definition":"A malignant neoplasm originating from the surface ovarian epithelium.  It accounts for the greatest number of deaths from malignancies of the female genital tract and is the fifth leading cause of cancer fatalities in women.  It is predominantly a disease of older white women of northern European extraction, but it is seen in all ages and ethnic groups.  Adenocarcinomas constitute the vast majority of ovarian carcinomas.  The pattern of metastatic spread in ovarian carcinoma is similar regardless of the microscopic type.  The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver.  Lung and pleura are the most common sites of extra-abdominal spread.  The primary form of therapy is surgical.  The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"286E976F-6E43-3730-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-01","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E4614-8D37-4361-E063-731AD00ABCAB","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"TYRRELLM","dateModified":"2023-11-02","deletedIndicator":"No"},{"value":"Ovarian cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"3210710","version":"1","preferredName":"Malignant Ovarian Neoplasm","longName":"3210710","preferredDefinition":"A primary or metastatic malignant tumor involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Ovarian Neoplasm","conceptCode":"C7431","definition":"A primary or metastatic malignant neoplasm involving the ovary. Most primary malignant ovarian neoplasms are either carcinomas (serous, mucinous, or endometrioid adenocarcinomas) or malignant germ cell tumors. Metastatic malignant neoplasms to the ovary include carcinomas, lymphomas, and melanomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9248-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E4614-8D38-4361-E063-731AD00ABCAB","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"TYRRELLM","dateModified":"2023-11-02","deletedIndicator":"No"},{"value":"Serous endometrial adenocarcinoma","valueDescription":null,"ValueMeaning":{"publicId":"3104169","version":"1","preferredName":"Endometrial Serous Adenocarcinoma","longName":"3104169","preferredDefinition":"A high grade, aggressive adenocarcinoma arising from the endometrium.  It is characterized by the presence of complex papillary patterns with cellular budding.  Atypical mitoses, necrosis, and psammoma bodies may be present.  It is classified as type II endometrial carcinoma and it is not associated with endometrial hyperplasia.  It tends to invade deeply into the myometrium and spreads into the lymphatic vessels.  Patients frequently present with spread of the tumor beyond the uterus at the time of diagnosis.  The prognosis is usually poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrial Serous Adenocarcinoma","conceptCode":"C27838","definition":"A high-grade, aggressive adenocarcinoma arising from the endometrium. It is characterized by the presence of complex papillary patterns with cellular budding. Atypical mitoses, necrosis, and psammoma bodies may be present. It is classified as type II endometrial carcinoma and it is not associated with endometrial hyperplasia. It tends to invade deeply into the myometrium and spreads into the lymphatic vessels. Patients frequently present with spread of the tumor beyond the uterus at the time of diagnosis. The prognosis is usually poor.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"87E99CE1-B739-EEEA-E040-BB89AD43141F","latestVersionIndicator":"Yes","beginDate":"2010-05-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-31","modifiedBy":"COOPERM","dateModified":"2011-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E4614-8D39-4361-E063-731AD00ABCAB","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"TYRRELLM","dateModified":"2023-11-02","deletedIndicator":"No"},{"value":"Squamous cervical cancer","valueDescription":null,"ValueMeaning":{"publicId":"3521937","version":"1","preferredName":"Cervical Squamous Cell Carcinoma","longName":"3521937","preferredDefinition":"A squamous cell carcinoma arising from the cervical epithelium. It usually evolves from a precancerous cervical lesion. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors for cervical squamous cell carcinoma. The following histologic patterns have been described: Conventional squamous cell carcinoma, papillary squamous cell carcinoma, transitional cell carcinoma, lymphoepithelioma-like carcinoma, verrucous carcinoma, condylomatous carcinoma and spindle cell carcinoma. Survival is most closely related to the stage of disease at the time of diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical Squamous Cell Carcinoma","conceptCode":"C4028","definition":"A squamous cell carcinoma arising from the cervical epithelium. It usually evolves from a precancerous cervical lesion. Increased numbers of sexual partners and human papillomavirus (HPV) infection are risk factors for cervical squamous cell carcinoma. Survival is most closely related to the stage of disease at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C47BC307-6801-000B-E040-BB89AD43320C","latestVersionIndicator":"Yes","beginDate":"2012-07-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-07-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E55C8-2A22-469D-E063-731AD00ACEAB","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"TYRRELLM","dateModified":"2023-11-02","deletedIndicator":"No"},{"value":"Uterine cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"5581345","version":"1","preferredName":"Malignant Uterine Neoplasm","longName":"5581345","preferredDefinition":"Primary or metastatic malignant neoplasm involving the uterine corpus and/or the cervix.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Uterine Neoplasm","conceptCode":"C3552","definition":"Primary or metastatic malignant neoplasm involving the uterine corpus and/or the cervix.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B90B-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"092E55C8-2A23-469D-E063-731AD00ACEAB","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"TYRRELLM","dateModified":"2023-11-02","deletedIndicator":"No"},{"value":"Vascular tumor, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722589","version":"1","preferredName":"Vascular Neoplasm","longName":"4722589","preferredDefinition":"A benign or malignant neoplasm arising from vascular tissue including arteries, veins, venous sinuses, arterioles and capillaries. It may occur in essentially any body location and is characterized by the presence of vascular channel formation and endothelial cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vascular Neoplasm","conceptCode":"C7388","definition":"A benign, intermediate, or malignant neoplasm arising from vascular tissue including arteries, veins, venous sinuses, lymphatic vessels, arterioles and capillaries. It may occur in essentially any body location and is characterized by the presence of vascular channel formation and endothelial cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-BA2C-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE28-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Dermatofibrosarcoma","valueDescription":null,"ValueMeaning":{"publicId":"4824411","version":"1","preferredName":"Dermatofibrosarcoma Protuberans","longName":"4824411","preferredDefinition":"A low grade fibroblastic neoplasm presenting as a nodular cutaneous mass, most often on the trunk and the proximal extremities.  The tumor diffusely infiltrates the dermis and the subcutaneous tissues.  It is considered a locally aggressive neoplasm, which often recurs but rarely metastasizes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dermatofibrosarcoma Protuberans","conceptCode":"C4683","definition":"A low grade fibroblastic neoplasm presenting as a nodular cutaneous mass, most often on the trunk and the proximal extremities.  The tumor diffusely infiltrates the dermis and the subcutaneous tissues.  It is considered a locally aggressive neoplasm, which often recurs but rarely metastasizes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B5CB-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE29-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Neuroendocrine cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"5340871","version":"1","preferredName":"Neuroendocrine Carcinoma","longName":"5340871","preferredDefinition":"A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroendocrine Carcinoma","conceptCode":"C3773","definition":"A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"375CBC91-9462-3C74-E050-BB89AD4344B9","latestVersionIndicator":"Yes","beginDate":"2016-07-11","endDate":null,"createdBy":"MAESKEB","dateCreated":"2016-07-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE2A-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Bronchioloalveolar carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"3106712","version":"1","preferredName":"Bronchioalveolar Carcinoma","longName":"3106712","preferredDefinition":"A solitary adenocarcinoma arising from the lung measuring 3 cm or less. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minimally Invasive Lung Adenocarcinoma","conceptCode":"C2923","definition":"A solitary adenocarcinoma arising from the lung and measuring 3 cm or less in size. It is characterized by a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. It is usually a non-mucinous adenocarcinoma, but rarely may be mucinous.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"883834AB-0D26-C6A6-E040-BB89AD431A8D","latestVersionIndicator":"Yes","beginDate":"2010-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-04","modifiedBy":"COOPERM","dateModified":"2019-04-10","changeDescription":"Updated definition to match current NCIt. 4.10.19 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE2B-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Metastases to brain parenchyma, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722600","version":"1","preferredName":"Metastatic Malignant Neoplasm in the Brain","longName":"4722600","preferredDefinition":"A malignant neoplasm that has spread to the brain from another anatomic site or system. The majority are carcinomas (usually lung or breast carcinomas).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Malignant Neoplasm in the Brain","conceptCode":"C3813","definition":"A malignant neoplasm that has spread to the brain from another anatomic site or system. The majority are carcinomas (usually lung or breast carcinomas).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A2532-F900-F227-E050-BB89AD433E96","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE2C-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Penile squamous carcinoma (epidermoid)","valueDescription":null,"ValueMeaning":{"publicId":"4722584","version":"1","preferredName":"Squamous Cell Carcinoma of the Penis","longName":"4722584","preferredDefinition":"A squamous cell carcinoma arising from the penis.  It occurs chiefly in the squamous epithelium of the glans, coronal sulcus, and foreskin.  Etiologic factors include phimosis, lichen sclerosus, smoking, ultraviolet irradiation, history of warts or condylomas, and lack of circumcision.  Human papilloma virus is present in a subset of penile squamous cell carcinomas.  Patients may present with an exophytic or flat ulcerative mass in the glans or a large primary tumor with inguinal nodal and skin metastases.  Morphologic variants include the basaloid carcinoma, warty (condylomatous) carcinoma, verrucous carcinoma, and sarcomatoid (spindle cell) carcinoma. (WHO, 2004)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Penile Squamous Cell Carcinoma","conceptCode":"C7729","definition":"A squamous cell carcinoma arising from the penis.  It occurs chiefly in the squamous epithelium of the glans, coronal sulcus, and foreskin.  Etiologic factors include phimosis, lichen sclerosus, smoking, ultraviolet irradiation, history of warts or condylomas, and lack of circumcision.  Human papilloma virus is present in a subset of penile squamous cell carcinomas.  Patients may present with an exophytic or flat ulcerative mass in the glans or a large primary tumor with inguinal nodal and skin metastases. (WHO, 2004)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B93C-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE2D-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Head and neck squamous cell carcinoma, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722786","version":"1","preferredName":"Head and Neck Squamous Cell Carcinoma","longName":"4722786","preferredDefinition":"A squamous cell carcinoma that arises from any of the following anatomic sites: lip and oral cavity, nasal cavity, paranasal sinuses, pharynx, larynx, and salivary glands.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck Squamous Cell Carcinoma","conceptCode":"C34447","definition":"A squamous cell carcinoma that arises from any of the following anatomic sites: lip and oral cavity, nasal cavity, paranasal sinuses, pharynx, larynx, and salivary glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-23F6-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE2E-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Soft tissue neoplasm, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722494","version":"1","preferredName":"Soft Tissue Neoplasm","longName":"4722494","preferredDefinition":"A benign or malignant neoplasm that arises from mesenchymal cells in extra skeletal sites.  The most common types are lipomatous (fatty), vascular, smooth muscle, fibrous, and fibrohistiocytic neoplasms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Neoplasm","conceptCode":"C3377","definition":"A benign, intermediate, or malignant neoplasm that arises from the soft tissue.  The most common types are lipomatous (fatty), vascular, smooth muscle, fibrous, and fibrohistiocytic neoplasms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8748A7-4713-DF2B-E050-BB89AD4311E0","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE2F-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Desmoplastic small round cell tumor","valueDescription":null,"ValueMeaning":{"publicId":"3179342","version":"1","preferredName":"Desmoplastic Small Round Cell Tumor","longName":"3179342","preferredDefinition":"An aggressive malignant neoplasm of uncertain lineage.  It is characterized by the presence of small round cells in a desmoplastic stroma.  It usually affects children and young adults.  The most common site of involvement is the abdomen.  Patients usually present with abdominal distention, pain, ascites, and a palpable abdominal mass.  The prognosis is usually poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Desmoplastic Small Round Cell Tumor","conceptCode":"C8300","definition":"An aggressive malignant soft tissue neoplasm of uncertain differentiation.  It is characterized by a recurrent chromosomal translocation t(11;22)(p13;q12) and the presence of small round cells in a desmoplastic stroma.  It usually affects children and young adults.  The most common site of involvement is the abdomen.  Patients usually present with abdominal distention, pain, ascites, and a palpable abdominal mass.  The prognosis is usually poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-8341-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE30-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Germinoma of CNS","valueDescription":null,"ValueMeaning":{"publicId":"4722577","version":"1","preferredName":"Central Nervous System Germinoma","longName":"4722577","preferredDefinition":"A malignant germ cell tumor arising from the central nervous system.  It is composed of uniform cells resembling primitive germ cells.  These cells have large, vesicular nuclei, prominent nucleoli and a clear, glycogen-rich cytoplasm.  Additional features are lymphoid or lymphoplasmacytic infiltrates and, less frequently, scattered syncytiotrophoblastic giant cells.  (Adapted from WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Germinoma","conceptCode":"C7009","definition":"A malignant germ cell tumor arising from the central nervous system.  It is composed of uniform cells resembling primitive germ cells.  These cells have large, vesicular nuclei, prominent nucleoli and a clear, glycogen-rich cytoplasm.  Additional features are lymphoid or lymphoplasmacytic infiltrates and, less frequently, scattered syncytiotrophoblastic giant cells.  (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F899F68-B716-D077-E050-BB89AD434EE9","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SOKKERL","dateModified":"2024-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE31-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Nongerminomatous germ cell tumor of the CNS","valueDescription":null,"ValueMeaning":{"publicId":"4722573","version":"1","preferredName":"Nongerminomatous Germ Cell Tumor","longName":"4722573","preferredDefinition":"Germ cell tumors of the central nervous system other than germinoma.  This category includes teratoma, choriocarcinoma, embryonal carcinoma, and yolk sac tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System Nongerminomatous Germ Cell Tumor","conceptCode":"C100093","definition":"Germ cell tumors of the central nervous system other than germinoma.  This category includes teratoma, choriocarcinoma, embryonal carcinoma, and yolk sac tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F899F68-B6F0-D077-E050-BB89AD434EE9","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE32-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Ovarian stromal cancer","valueDescription":null,"ValueMeaning":{"publicId":"4722586","version":"1","preferredName":"Malignant Ovarian Surface Epithelial-Stromal Tumor","longName":"4722586","preferredDefinition":"An invasive malignant neoplasm that originates from the surface epithelium of the ovary.  It is composed of malignant epithelial cells and stroma.  Representative examples include serous adenocarcinoma, mucinous adenocarcinoma, endometrioid adenocarcinoma, clear cell adenocarcinoma, and malignant Brenner tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Ovarian Epithelial Tumor","conceptCode":"C40026","definition":"An invasive malignant tumor that originates from the surface epithelium of the ovary.  It is composed of malignant epithelial cells and stroma.  Representative examples include serous adenocarcinoma, mucinous adenocarcinoma, endometrioid adenocarcinoma, clear cell adenocarcinoma, and malignant Brenner tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B9B9-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE33-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Adenocarcinoma of the stomach","valueDescription":null,"ValueMeaning":{"publicId":"3206052","version":"1","preferredName":"Gastric Adenocarcinoma","longName":"3206052","preferredDefinition":"An adenocarcinoma arising from the stomach glandular epithelium. Gastric adenocarcinoma is primarily a disease of older individuals, most commonly develops after a long period of atrophic gastritis and is strongly associated with Helicobacter pylori infection. The lack of early symptoms often delays the diagnosis of gastric cancer. The majority of patients present with advanced tumors which have poor rates of curability. Microscopically, two important histologic types of gastric adenocarcinoma are recognized: the intestinal and diffuse type. The overall prognosis of gastric adenocarcinomas is poor, even in patients who receive a \"curative\" resection (adapted from Sternberg's Surgical Pathology, 3rd ed., 1999).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Adenocarcinoma","conceptCode":"C4004","definition":"An adenocarcinoma arising from the stomach glandular epithelium. Gastric adenocarcinoma is primarily a disease of older individuals.  It most commonly develops after a long period of atrophic gastritis and is strongly associated with Helicobacter pylori infection. The lack of early symptoms often delays the diagnosis of gastric cancer. The majority of patients present with advanced tumors which have poor rates of curability. Microscopically, two important histologic types of gastric adenocarcinoma are recognized: the intestinal and diffuse type. The overall prognosis of gastric adenocarcinomas is poor, even in patients who receive a \"curative\" resection (adapted from Sternberg's Surgical Pathology, 3rd ed., 1999).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F03F2AF-4F8F-0E9A-E040-BB89AD436762","latestVersionIndicator":"Yes","beginDate":"2011-03-21","endDate":null,"createdBy":"BLABOLIJ","dateCreated":"2011-03-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE34-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Infantile fibrosarcoma (congenital fibrosarcoma)","valueDescription":null,"ValueMeaning":{"publicId":"4824405","version":"1","preferredName":"Infantile Fibrosarcoma","longName":"4824405","preferredDefinition":"A fibrosarcoma that occurs in infants.  It shares identical morphologic features with adult fibrosarcoma but carries the t(12;15)(p13;q25) translocation that results in ETV6-NTRK3 gene fusion.  It usually affects the superficial and deep soft tissues of the extremities.  The prognosis is generally much more favorable than for adult fibrosarcoma, and it rarely metastasizes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infantile Fibrosarcoma","conceptCode":"C4244","definition":"A fibrosarcoma that occurs in infants.  It shares identical morphologic features with adult fibrosarcoma but carries the t(12;15)(p13;q25) translocation that results in ETV6-NTRK3 gene fusion.  It usually affects the superficial and deep soft tissues of the extremities.  The prognosis is generally much more favorable than for adult fibrosarcoma, and it rarely metastasizes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B4E9-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE35-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Adenocarcinoma, NOS","valueDescription":null,"ValueMeaning":{"publicId":"2831117","version":"1","preferredName":"Adenocarcinoma","longName":"2831117","preferredDefinition":"carcinoma derived from glandular tissue or in which tumor cells form recognizable glandular structures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"61F598EF-7D06-BDE9-E040-BB89AD43552F","latestVersionIndicator":"Yes","beginDate":"2009-02-02","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-02-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE36-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Hurthle cell neoplasm (thyroid)","valueDescription":null,"ValueMeaning":{"publicId":"4722737","version":"1","preferredName":"Thyroid Gland Oncocytic Neoplasm","longName":"4722737","preferredDefinition":"An adenoma or carcinoma arising from the follicular cells of the thyroid gland.  It is composed of large oncocytic cells with abundant granular eosinophilic cytoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Oncocytic Neoplasm","conceptCode":"C46068","definition":"An adenoma or carcinoma arising from the follicular cells of the thyroid gland.  It is composed of large oncocytic cells with abundant granular eosinophilic cytoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1F5E-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE37-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Adrenocortical carcinoma, NOS","valueDescription":null,"ValueMeaning":{"publicId":"3248212","version":"1","preferredName":"Adrenal Cortex Carcinoma","longName":"3248212","preferredDefinition":"A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells.  Symptoms are usually related to the excessive production of hormones, and include Cushing's syndrome and virilism in women.  Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes.  Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Cortical Carcinoma","conceptCode":"C9325","definition":"A rare, usually large (greater than 5cm), malignant epithelial tumor arising from the adrenal cortical cells.  Symptoms are usually related to the excessive production of hormones, and include Cushing's syndrome and virilism in women.  Common sites of metastasis include liver, lung, bone, and retroperitoneal lymph nodes.  Advanced radiologic procedures have enabled the detection of small tumors, resulting in the improvement of the 5-year survival.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B537E2-7FB8-5E57-E040-BB89AD4339B4","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE38-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Clear cell sarcoma/Malignant melanoma of soft parts (excluding Clear cell sarcoma of the kidney)","valueDescription":null,"ValueMeaning":{"publicId":"3179239","version":"1","preferredName":"Clear Cell Sarcoma of Soft Tissue","longName":"3179239","preferredDefinition":"A rare malignant neoplasm with melanocytic differentiation characterized by the presence of polygonal or spindle shaped clear cells. This sarcoma usually affects the tendons and aponeuroses and is associated with a poor prognosis due to recurrences and metastases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Sarcoma of Soft Tissue","conceptCode":"C3745","definition":"A rare malignant neoplasm with melanocytic differentiation characterized by the presence of polygonal or spindle shaped clear cells. This sarcoma usually affects the tendons and aponeuroses and is associated with a poor prognosis due to recurrences and metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9881C41C-CE10-C63B-E040-BB89AD437873","latestVersionIndicator":"Yes","beginDate":"2010-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-28","modifiedBy":"ONEDATA","dateModified":"2010-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE39-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Alveolar soft part sarcoma","valueDescription":null,"ValueMeaning":{"publicId":"3179234","version":"1","preferredName":"Alveolar Soft Part Sarcoma","longName":"3179234","preferredDefinition":"A rare malignant neoplasm characterized by the presence of large epithelioid cells with abundant cytoplasm forming nests and pseudoalveolar structures. The groups of the epithelioid cells are separated by thin-walled sinusoidal spaces. It occurs most often in adolescents and young adults. In adults the most common sites of involvement are the extremities, and in infants and children, the head and neck. It usually presents as a slowly growing mass and it frequently metastasizes to other anatomic sites. The most common sites of metastasis are the lungs, bone, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alveolar Soft Part Sarcoma","conceptCode":"C3750","definition":"A rare malignant neoplasm characterized by the presence of large epithelioid cells with abundant cytoplasm forming nests and pseudoalveolar structures. The groups of the epithelioid cells are separated by thin-walled sinusoidal spaces. It occurs most often in adolescents and young adults. In adults the most common sites of involvement are the extremities, and in infants and children, the head and neck. It usually presents as a slowly growing mass and it frequently metastasizes to other anatomic sites. The most common sites of metastasis are the lungs, bone, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9881C41C-CD57-C63B-E040-BB89AD437873","latestVersionIndicator":"Yes","beginDate":"2010-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-28","modifiedBy":"ONEDATA","dateModified":"2010-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE3A-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Plexiform neurofibroma","valueDescription":null,"ValueMeaning":{"publicId":"2838639","version":"1","preferredName":"Plexiform Neurofibroma","longName":"2838639","preferredDefinition":"An elongated and multinodular neurofibroma, formed when the tumor involves either multiple trunks of a plexus or multiple fascicles of a large nerve, such as the sciatic. Some plexiform neurofibromas resemble a bag of worms, others produce a massive ropy enlargement of the nerve. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Plexiform Neurofibroma","conceptCode":"C3797","definition":"An elongated and multinodular neurofibroma, formed when the tumor involves either multiple trunks of a plexus or multiple fascicles of a large nerve, such as the sciatic. Some plexiform neurofibromas resemble a bag of worms, others produce a massive ropy enlargement of the nerve. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A6E019-5A5E-F2F6-E040-BB89AD4350E9","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE3B-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Anal cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722735","version":"1","preferredName":"Anal Carcinoma","longName":"4722735","preferredDefinition":"A carcinoma that arises from the anus.  Anal carcinomas include the anal canal and anal margin (perianal skin) carcinomas.  The anal margin carcinoma is staged separately as a skin carcinoma.  Anal cancer stage terms are used as synonyms for anal canal cancer stage terms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anal Carcinoma","conceptCode":"C9291","definition":"A carcinoma that arises from the anus. Anal carcinomas include the anal canal and perianal area (anal margin) carcinomas. Perianal carcinomas are staged separately as skin carcinomas in AJCC v6 and v7 editions. The AJCC v8 edition staging system applies to all carcinomas arising in the anal canal, including carcinomas that arise within anorectal fistulas and those arising in the perianal area (anal margin).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1ED1-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE3C-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Alveolar rhabdomyosarcoma","valueDescription":null,"ValueMeaning":{"publicId":"3179233","version":"1","preferredName":"Alveolar Rhabdomyosarcoma","longName":"3179233","preferredDefinition":"A rapidly growing malignant mesenchymal neoplasm. It is characterized by the presence of round cells with myoblastic differentiation and a fibrovascular stroma resembling an alveolar growth pattern. The tumor usually presents in the extremities.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Alveolar Rhabdomyosarcoma","conceptCode":"C3749","definition":"A rapidly growing malignant mesenchymal neoplasm. It is characterized by the presence of round cells with myoblastic differentiation and a fibrovascular stroma resembling an alveolar growth pattern. The tumor usually presents in the extremities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9881C41C-CD32-C63B-E040-BB89AD437873","latestVersionIndicator":"Yes","beginDate":"2010-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-28","modifiedBy":"ONEDATA","dateModified":"2010-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE3D-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Anaplastic thyroid carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"4722738","version":"1","preferredName":"Thyroid Gland Undifferentiated (Anaplastic) Carcinoma","longName":"4722738","preferredDefinition":"A primary carcinoma of the thyroid gland composed of undifferentiated cells.  The malignant cells demonstrate evidence of epithelial differentiation, either by immunohistochemistry or electron microscopic studies. Microscopically, in the majority of cases there is a mixture of spindle, epithelioid, and giant cells. The vast majority of the patients present with a rapidly enlarging neck mass. The clinical course is usually aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Anaplastic Carcinoma","conceptCode":"C3878","definition":"A primary carcinoma of the thyroid gland composed of undifferentiated cells.  The malignant cells demonstrate evidence of epithelial differentiation, either by immunohistochemistry or electron microscopic studies. Microscopically, in the majority of cases there is a mixture of spindle, epithelioid, and giant cells. The vast majority of the patients present with a rapidly enlarging neck mass. The clinical course is usually aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1F95-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE3E-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Embryonal rhabdomyosarcoma","valueDescription":null,"ValueMeaning":{"publicId":"4824381","version":"1","preferredName":"Embryonal Rhabdomyosarcoma","longName":"4824381","preferredDefinition":"A poorly circumscribed morphologic variant of rhabdomyosarcoma.  It is characterized by the presence of primitive skeletal muscle differentiation in any stage of myogenesis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Embryonal Rhabdomyosarcoma","conceptCode":"C8971","definition":"A poorly circumscribed morphologic variant of rhabdomyosarcoma.  It is characterized by the presence of primitive skeletal muscle differentiation in any stage of myogenesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B254-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE3F-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Low-grade astrocytoma, NOS","valueDescription":null,"ValueMeaning":{"publicId":"2578704","version":"1","preferredName":"Diffuse astrocytoma","longName":"2578704","preferredDefinition":"A low-grade (WHO grade II) astrocytic neoplasm. It is characterized by diffuse infiltration of neighboring central nervous system structures. These lesions typically affect young adults and have a tendency for progression to anaplastic astrocytoma and glioblastoma. Based on the IDH genes mutation status, diffuse astrocytomas are classified as IDH-mutant, IDH-wildtype, and not otherwise specified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Astrocytoma","conceptCode":"C7173","definition":"A low-grade (WHO grade 2) astrocytic neoplasm. It is characterized by diffuse infiltration of neighboring central nervous system structures. These lesions typically affect young adults and have a tendency for progression to anaplastic astrocytoma and glioblastoma. Based on the IDH genes mutation status, diffuse astrocytomas are classified as IDH-mutant, IDH-wildtype, and not otherwise specified.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-007D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-10","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2004-03-10","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE40-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Fibrillary astrocytoma","valueDescription":null,"ValueMeaning":{"publicId":"2578707","version":"1","preferredName":"Fibrillary astrocytoma","longName":"2578707","preferredDefinition":"The most frequent histological variant of diffuse astrocytoma. It is predominantly composed of fibrillary neoplastic astrocytes. Nuclear atypia is a diagnostic criterion but mitotic activity, necrosis and microvascular proliferation are absent.  The occasional or regional occurrence of gemistocytic neoplastic cells is compatible with the diagnosis of fibrillary astrocytoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrillary Astrocytoma","conceptCode":"C4322","definition":"The most frequent histological variant of diffuse astrocytoma. It is predominantly composed of fibrillary neoplastic astrocytes. Nuclear atypia is a diagnostic criterion but mitotic activity, necrosis and microvascular proliferation are absent.  The occasional or regional occurrence of gemistocytic neoplastic cells is compatible with the diagnosis of fibrillary astrocytoma. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0080-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-23","modifiedBy":"PWEST","dateModified":"2014-05-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE41-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Basal cell carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"6796707","version":"1","preferredName":"Basal Cell Carcinoma","longName":"6796707","preferredDefinition":"A carcinoma involving the basal cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Basal Cell Carcinoma","conceptCode":"C156767","definition":"A carcinoma involving the basal cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8C5201B3-6FFD-5291-E053-F662850A82DE","latestVersionIndicator":"Yes","beginDate":"2019-06-27","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-27","modifiedBy":"ONEDATA","dateModified":"2019-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE42-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Cystadenocarcinoma of the pancreas","valueDescription":null,"ValueMeaning":{"publicId":"4722722","version":"1","preferredName":"Pancreatic Cystadenocarcinoma","longName":"4722722v1.00","preferredDefinition":"A cystic adenocarcinoma that arises from the pancreas. It includes the acinar cell and serous cystadenocarcinoma subtypes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Cystadenocarcinoma","conceptCode":"C3874","definition":"A cystic adenocarcinoma that arises from the pancreas. It includes the acinar cell and serous cystadenocarcinoma subtypes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1CD2-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"KUMMEROA","dateModified":"2023-08-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE43-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Cholangiocarcinoma, intrahepatic and extrahepatic bile ducts (adenocarcinoma)","valueDescription":null,"ValueMeaning":{"publicId":"4722725","version":"1","preferredName":"Cholangiocarcinoma","longName":"4722725","preferredDefinition":"A carcinoma that arises from the intrahepatic biliary tree (intrahepatic cholangiocarcinoma) or from the junction, or adjacent to the junction, of the right and left hepatic ducts (hilar cholangiocarcinoma). Grossly, the malignant lesions are solid, nodular, and grayish. Morphologically, the vast majority of cases are adenocarcinomas. Signs and symptoms include malaise, weight loss, right upper quadrant abdominal pain, and night sweats. Early detection is difficult and the prognosis is generally poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cholangiocarcinoma","conceptCode":"C4436","definition":"A carcinoma that arises from the intrahepatic bile ducts, the hepatic ducts, or the common bile duct distal to the insertion of the cystic duct. The vast majority of tumors are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1D7B-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE44-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Collecting duct renal cancer","valueDescription":null,"ValueMeaning":{"publicId":"2581666","version":"1","preferredName":"Carcinoma of the Collecting Ducts of Bellini","longName":"2581666","preferredDefinition":"Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Collecting Duct Carcinoma","conceptCode":"C6194","definition":"Also known as collecting duct carcinoma, this is a rare type of renal carcinoma. It arises from the collecting ducts of the renal medulla, and most authors suggest that this is an aggressive tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C0F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-09","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-09","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE45-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Diffuse brainstem glioma","valueDescription":null,"ValueMeaning":{"publicId":"4722559","version":"1","preferredName":"Brain Stem Glioma","longName":"4722559","preferredDefinition":"A neuroglial tumor that arises from the brain stem.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Brain Stem Glioma","conceptCode":"C8501","definition":"A glioma that arises from the brain stem.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B764-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE46-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Renal cell carcinoma with sarcomatoid features","valueDescription":null,"ValueMeaning":{"publicId":"2581627","version":"1","preferredName":"Sarcomatoid Renal Cell Carcinoma","longName":"2581627","preferredDefinition":"A high grade carcinoma of the kidney.  It is not a distinct clinicopathological entity and includes a diverse group of renal cell carcinomas which have been transformed from a lower to a higher grade.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sarcomatoid Renal Cell Carcinoma","conceptCode":"C27893","definition":"A high grade carcinoma of the kidney.  It is not a distinct clinicopathological entity and includes a diverse group of renal cell carcinomas which have been transformed from a lower to a higher grade.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0BE8-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-07","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-07","modifiedBy":"COOPERM","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE47-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Carcinoid tumor","valueDescription":null,"ValueMeaning":{"publicId":"2956072","version":"1","preferredName":"Carcinoid Tumor","longName":"2956072","preferredDefinition":"Carcinoid tumor, also known as well differentiated endocrine neoplasm, is a slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.  The tumor may show a variety of patterns, such as solid, trabecular, and acinar.  Electron microscopy shows small secretory granules.  Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity.  Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen.  Such cases may have an aggressive clinical course.  Gastrointestinal tract and lung are common sites of involvement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoid Tumor","conceptCode":"C2915","definition":"A slow growing neuroendocrine tumor, composed of uniform, round, or polygonal cells having monotonous, centrally located nuclei and small nucleoli, infrequent mitoses, and no necrosis.  The tumor may show a variety of patterns, such as solid, trabecular, and acinar.  Electron microscopy shows small secretory granules.  Immunohistochemical studies reveal NSE, as well as chromogranin immunoreactivity.  Malignant histology (cellular pleomorphism, hyperchromatic nuclei, prominent nucleoli, necrosis, and mitoses) can occasionally be seen.  Such cases may have an aggressive clinical course.  Gastrointestinal tract and lung are common sites of involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76EBECE2-B719-A0E2-E040-BB89AD435984","latestVersionIndicator":"Yes","beginDate":"2009-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE48-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Adenocarcinoma of the gastroesophageal junction","valueDescription":null,"ValueMeaning":{"publicId":"4722731","version":"1","preferredName":"Adenocarcinoma of the Gastroesophageal Junction","longName":"4722731","preferredDefinition":"An adenocarcinoma that arises from and straddles the junction of the stomach and esophagus.  The category of adenocarcinomas of the gastroesophageal junction also includes the majority of adenocarcinomas previously called gastric cardia adenocarcinomas.  Squamous cell carcinomas that affect or cross the junction of the stomach and esophagus are classified as carcinomas of the distal esophagus.  Adenocarcinoma of the gastroesophageal junction occurs more often in Caucasian middle aged and elderly males.  Clinical signs and symptoms include dysphagia, abdominal pain, and weight loss.  The prognosis depends on the completeness of the surgical resection, the number of lymph nodes involved by cancer, and the presence or absence of postoperative complications.  The presence of TP53 mutations indicates worse prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastroesophageal Junction Adenocarcinoma","conceptCode":"C9296","definition":"An adenocarcinoma that arises from and straddles the junction of the stomach and esophagus. The category of adenocarcinomas of the gastroesophageal junction also includes the majority of adenocarcinomas previously called gastric cardia adenocarcinomas. Squamous cell carcinomas that affect or cross the junction of the stomach and esophagus are classified as carcinomas of the distal esophagus. Adenocarcinoma of the gastroesophageal junction occurs more often in Caucasian middle aged and elderly males. Clinical signs and symptoms include dysphagia, abdominal pain, and weight loss. The prognosis depends on the completeness of the surgical resection, the number of lymph nodes involved by cancer, and the presence or absence of postoperative complications. The presence of TP53 mutations indicates worse prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1E27-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE49-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Carcinoma, NOS","valueDescription":null,"ValueMeaning":{"publicId":"2935533","version":"1","preferredName":"Carcinoma","longName":"2935533","preferredDefinition":"A malignant tumor arising from epithelial cells.  Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas.  Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis.  Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites.  Lung carcinoma, skin carcinoma, breast carcinoma, and prostate carcinoma are the most frequently seen carcinomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71F88553-C4BB-17CC-E040-BB89AD43398B","latestVersionIndicator":"Yes","beginDate":"2009-08-25","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-08-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE4A-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Pilocytic astrocytoma","valueDescription":null,"ValueMeaning":{"publicId":"2578708","version":"1","preferredName":"Pilocytic astrocytoma","longName":"2578708","preferredDefinition":"Pilocytic Astrocytoma, the most common glioma in children, is a WHO grade I astrocytic tumor. It is a generally well circumscribed, slowly growing, often cystic, astrocytoma. It is histologically characterized by a biphasic pattern with varying proportion of compacted bipolar cells which may have Rosenthal fibers (tapered corkscrew-shaped, brightly eosinophilic, intracytoplasmic hyaline masses) and loose textured multipolar cells with microcysts and granular bodies. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pilocytic Astrocytoma","conceptCode":"C4047","definition":"A WHO grade 1, relatively circumscribed, slowly growing, often cystic astrocytoma occurring in children and young adults.  Histologically it is characterized by a biphasic pattern with compacted bipolar cells associated with Rosenthal fibers and multipolar cells associated with microcysts and eosinophilic bodies/hyaline droplets. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0081-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE4B-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"CNS primary tumor, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722556","version":"1","preferredName":"Primary Central Nervous System Neoplasm","longName":"4722556","preferredDefinition":"A benign or malignant neoplasm that arises from the brain or the spinal cord.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Central Nervous System Neoplasm","conceptCode":"C102871","definition":"A benign or malignant neoplasm that arises from the brain or the spinal cord.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B6E7-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE4C-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Choroid plexus carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"2578711","version":"1","preferredName":"Choroid plexus carcinoma","longName":"2578711","preferredDefinition":"Choroid Plexus Carcinoma (WHO grade III) is a malignant Choroid Plexus Tumor which shows anaplastic features and usually invades neighboring brain structures. CSF metastases are frequent. (Adapted from WHO.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Choroid Plexus Carcinoma","conceptCode":"C4715","definition":"A malignant neoplasm arising from the choroid plexus.  It shows anaplastic features and usually invades neighboring brain structures. Cerebrospinal fluid metastases are frequent. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0084-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE4D-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Chondrosarcoma","valueDescription":null,"ValueMeaning":{"publicId":"3179236","version":"1","preferredName":"Chondrosarcoma","longName":"3179236","preferredDefinition":"A malignant mesenchymal tumor arising from cartilage-forming tissues involving the bones.  It affects middle-aged to elderly adults, and the pelvic bones, ribs, shoulder girdle, and long bones are the most common sites of involvement.  Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chondrosarcoma","conceptCode":"C2946","definition":"A malignant cartilaginous matrix-producing mesenchymal neoplasm arising from the bone and soft tissue.  It usually affects middle-aged to elderly adults.  The pelvic bones, ribs, shoulder girdle, and long bones are the most common sites of involvement.  Most chondrosarcomas arise de novo, but some may develop in a preexisting benign cartilaginous lesion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9881C41C-CDA1-C63B-E040-BB89AD437873","latestVersionIndicator":"Yes","beginDate":"2010-12-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-28","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE4E-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Head and neck precancerous condition","valueDescription":null,"ValueMeaning":{"publicId":"4722788","version":"1","preferredName":"Head and Neck Precancerous Condition","longName":"4722788","preferredDefinition":"A premalignant pathologic process that affects the anatomic structures of the head and neck.  Representative examples include oral leukoplakia and leukoplakia of the vocal cords.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck Precancerous Condition","conceptCode":"C27642","definition":"A premalignant pathologic process that affects the anatomic structures of the head and neck.  Representative examples include oral leukoplakia and leukoplakia of the vocal cords.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-241C-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE4F-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Renal cell carcinoma, clear cell adenocarcinoma","valueDescription":null,"ValueMeaning":{"publicId":"3248533","version":"1","preferredName":"Clear Cell Renal Cell Carcinoma","longName":"3248533","preferredDefinition":"A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network.  The tumor may metastasize to unusual sites and late metastasis is common.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Renal Cell Carcinoma","conceptCode":"C4033","definition":"A malignant epithelial neoplasm of the kidney characterized by the presence of lipid-containing clear cells within a vascular network.  The tumor may metastasize to unusual sites and late metastasis is common.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6BBE041-B9CF-9503-E040-BB89AD435A00","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE50-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Penile adenocarcinoma","valueDescription":null,"ValueMeaning":{"publicId":"4722580","version":"1","preferredName":"Paget Disease of the Penis","longName":"4722580","preferredDefinition":"A premalignant condition morphologically characterised by the presence of the characteristic Paget cells in the intraepithelial tissue of the penis.  It presents as a smooth raised reddish area that may or may not be painful. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Penile Paget Disease","conceptCode":"C27817","definition":"A rare, slow-growing, usually non-invasive intraepithelial adenocarcinoma affecting the penile skin or mucosal surface. The malignant cells are large with abundant pale cytoplasm and vesicular nuclei with prominent nucleoli. (WHO 2016)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B8F0-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE51-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Clear cell sarcoma of the kidney","valueDescription":null,"ValueMeaning":{"publicId":"3210697","version":"1","preferredName":"Clear Cell Sarcoma of the Kidney","longName":"3210697","preferredDefinition":"A rare pediatric sarcoma affecting the kidney. It is characterized by the presence of epithelioid or spindle cells forming cords or nests, separated by fibrovascular septa. This type of sarcoma frequently metastasizes to the bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Sarcoma of the Kidney","conceptCode":"C4264","definition":"A rare pediatric sarcoma affecting the kidney. It is characterized by the presence of epithelioid or spindle cells forming cords or nests, separated by fibrovascular septa. It metastasizes to lung, bone, brain and soft tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-8FFE-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE52-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Lung adenocarcinoma with bronchioloalveolar features","valueDescription":null,"ValueMeaning":{"publicId":"3248503","version":"1","preferredName":"Lung Adenocarcinoma with Mixed Bronchioloalveolar and Invasive Components","longName":"3248503","preferredDefinition":"A lung adenocarcinoma consisting of a bronchioloalveolar component and an invasive adenocarcinomatous component.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Adenocarcinoma with Mixed Bronchioloalveolar and Invasive Components","conceptCode":"C65197","definition":"A lung adenocarcinoma consisting of a bronchioloalveolar component and an invasive adenocarcinomatous component.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B8531E-18DA-F891-E040-BB89AD4324F8","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"COOPERM","dateModified":"2011-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE53-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Adenocarcinoma of the colon","valueDescription":null,"ValueMeaning":{"publicId":"3088065","version":"1","preferredName":"Colon Adenocarcinoma","longName":"3088065","preferredDefinition":"An adenocarcinoma arising from the colon.  It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease.  Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits.  According to the degree of cellular differentiation, colonic adenocarcinomas are divided into well differentiated, moderately, and poorly differentiated.  Morphologic variants include the mucinous adenocarcinoma and signet-ring adenocarcinoma.  Lymphatic or hematogenous spread can occur early in the process and lead to systemic disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon Adenocarcinoma","conceptCode":"C4349","definition":"An adenocarcinoma arising from the colon.  It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease.  Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits.  According to the degree of cellular differentiation, colonic adenocarcinomas are divided into well, moderately, and poorly differentiated.  Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E18C0F-E290-9226-E040-BB89AD430EF0","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE54-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Pleural effusion, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4395771","version":"1","preferredName":"Pleural Effusion","longName":"4395771","preferredDefinition":"Increased amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough, and chest pain. It is usually caused by lung infections, congestive heart failure, pleural and lung tumors, connective tissue disorders, and trauma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pleural Effusion","conceptCode":"C3331","definition":"Increased amounts of fluid within the pleural cavity. Symptoms include shortness of breath, cough, and chest pain. It is usually caused by lung infections, congestive heart failure, pleural and lung tumors, connective tissue disorders, and trauma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D94A-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE55-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Colorectal cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722734","version":"1","preferredName":"Colorectal Carcinoma","longName":"4722734","preferredDefinition":"A malignant epithelial neoplasm that arises from the colon or rectum and invades through the muscularis mucosa into the submucosa.  The vast majority are adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal Carcinoma","conceptCode":"C2955","definition":"A malignant epithelial neoplasm that arises from the colon or rectum and invades through the muscularis mucosa into the submucosa.  The vast majority are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1E70-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE56-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Endocrine cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722740","version":"1","preferredName":"Malignant Endocrine Neoplasm","longName":"4722740","preferredDefinition":"A malignant neoplasm affecting the endocrine glands.  Representative examples include thyroid gland carcinoma, parathyroid gland carcinoma, pituitary gland carcinoma, and adrenal cortex carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Endocrine Neoplasm","conceptCode":"C3575","definition":"A malignant neoplasm affecting the endocrine glands.  Representative examples include thyroid gland carcinoma, parathyroid gland carcinoma, pituitary gland carcinoma, and adrenal cortex carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-202A-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE57-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Ewing sarcoma/Peripheral primitive neuroectodermal tumor","valueDescription":null,"ValueMeaning":{"publicId":"4265241","version":"1","preferredName":"Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor","longName":"4265241","preferredDefinition":"Round cell sarcomas with varying degrees of neuroectodermal differentiation.  There is a recurrent cytogenetic aberration, most commonly t(11;22)(q24;q12) and t(21;22)(q22;q12).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor","conceptCode":"C27291","definition":"A spectrum of malignant tumors, affecting mostly males under age 20, characterized morphologically by the presence of small round cells.  Ewing sarcoma and peripheral primitive neuroectodermal tumor represent the ends of a spectrum, with Ewing sarcoma lacking evidence of neural differentiation and the markers that characterize the peripheral primitive neuroectodermal tumor.  Ewing sarcoma and peripheral primitive neuroectodermal tumor may share cytogenetic abnormalities, proto-oncogene expression, cell culture and immunohistochemical abnormalities.  These tumors may occur in the soft tissues or the bones.  Pain and the presence of a mass are the most common clinical symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68C00B1-78E4-6438-E040-BB89AD4373BF","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE58-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Extragonadal germ cell tumors, NOS","valueDescription":null,"ValueMeaning":{"publicId":"3322765","version":"1","preferredName":"Extragonadal Germ Cell Tumor","longName":"3322765","preferredDefinition":"A germ cell tumor arising in an anatomic site other than the testis or ovary (e.g., central nervous system, lung, mediastinum, and retroperitoneum).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extragonadal Germ Cell Tumor","conceptCode":"C3918","definition":"A germ cell tumor arising in an anatomic site other than the testis or ovary (e.g., central nervous system, lung, mediastinum, and retroperitoneum).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B3714D57-A897-7A8F-E040-BB89AD43536C","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE59-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Fibrosarcoma (excluding infantile fibrosarcoma)","valueDescription":null,"ValueMeaning":{"publicId":"4824404","version":"1","preferredName":"Adult Fibrosarcoma","longName":"4824404","preferredDefinition":"A malignant mesenchymal tumor composed of fibroblasts, and characterized by collagen production and a herringbone architectural pattern.  It is more commonly seen in middle-aged and older adults.  It usually affects the deep soft tissues of extremities, trunk, head and neck.  Adult fibrosarcomas may recur and metastasise to the lungs and bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adult Fibrosarcoma","conceptCode":"C7809","definition":"A malignant mesenchymal neoplasm composed of fibroblasts.  It is characterized by collagen production and a herringbone architectural pattern.  It is more commonly seen in middle-aged and older adults.  It usually affects the deep soft tissues of extremities, trunk, head and neck.  Adult fibrosarcomas may recur and metastasize to the lungs and bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B4C6-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE5A-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Follicular thyroid carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"6779704","version":"1","preferredName":"Thyroid Gland Follicular Carcinoma","longName":"6779704","preferredDefinition":"A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  The nuclear features which characterise the thyroid gland papillary carcinoma are absent.  It is linked to radiation and comprises approximately 10% to 15% of thyroid cancers.  Clinically, it usually presents as a solitary mass in the thyroid gland.  It is generally unifocal and thickly encapsulated and shows invasion of the capsule or the vessels.  Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound and fine needle biopsy. Treatment options include: partial or complete thyroidectomy.  Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Follicular Carcinoma","conceptCode":"C8054","definition":"A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  The nuclear features which characterize the thyroid gland papillary carcinoma are absent.  Radiation exposure is a risk factor and it comprises approximately 10% to 15% of thyroid cancers.  Clinically, it usually presents as a solitary mass in the thyroid gland.  It is generally unifocal and thickly encapsulated and shows invasion of the capsule or the vessels.  Diagnostic procedures include thyroid ultrasound and fine needle biopsy.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8B112C4C-79C9-3C1F-E053-F662850A5A6E","latestVersionIndicator":"Yes","beginDate":"2019-06-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-06-11","modifiedBy":"ONEDATA","dateModified":"2019-06-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE5B-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Gall bladder carcinoma (adenocarcinoma)","valueDescription":null,"ValueMeaning":{"publicId":"5581349","version":"1","preferredName":"Gallbladder Carcinoma","longName":"5581349","preferredDefinition":"A malignant tumor arising from the epithelium of the gallbladder. It is usually associated with the presence of gallstones. Clinical symptoms are not specific and usually present late in the course. Morphologically, most gallbladder carcinomas are adenocarcinomas; squamous cell carcinomas, adenosquamous carcinomas, signet ring carcinomas, and undifferentiated carcinomas can also occur.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gallbladder Carcinoma","conceptCode":"C3844","definition":"A malignant tumor arising from the epithelium of the gallbladder. It is usually associated with the presence of gallstones. Clinical symptoms are not specific and usually present late in the course. Morphologically, most gallbladder carcinomas are adenocarcinomas; squamous cell carcinomas, adenosquamous carcinomas, signet ring carcinomas, and undifferentiated carcinomas can also occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B997-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE5C-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Gastric cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"5581343","version":"1","preferredName":"Gastric Carcinoma","longName":"5581343","preferredDefinition":"A malignant epithelial tumor of the stomach mucosa. The vast majority of gastric carcinomas are adenocarcinomas, arising from the gastric glandular epithelium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastric Carcinoma","conceptCode":"C4911","definition":"A malignant epithelial tumor of the stomach mucosa. The vast majority of gastric carcinomas are adenocarcinomas, arising from the gastric glandular epithelium.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B8C5-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE5D-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Gastrointestinal cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722726","version":"1","preferredName":"Malignant Digestive System Neoplasm","longName":"4722726","preferredDefinition":"A primary or metastatic malignant neoplasm involving any part of the digestive system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Digestive System Neoplasm","conceptCode":"C4890","definition":"A primary or metastatic malignant neoplasm involving any part of the digestive system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1D9E-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE5E-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Germ cell cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722797","version":"1","preferredName":"Malignant Germ Cell Tumor","longName":"4722797","preferredDefinition":"A gonadal or extragonadal malignant neoplasm that arises from germ cells. Representative examples include embryonal carcinoma, yolk sac tumor, and seminoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Germ Cell Tumor","conceptCode":"C4925","definition":"A gonadal or extragonadal malignant neoplasm that arises from germ cells. Representative examples include embryonal carcinoma, yolk sac tumor, and seminoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-24ED-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE5F-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Glioblastoma multiforme","valueDescription":null,"ValueMeaning":{"publicId":"3686274","version":"1","preferredName":"Glioblastoma","longName":"3686274","preferredDefinition":"The most malignant astrocytic tumor (WHO grade IV). It is composed of poorly differentiated neoplastic astrocytes and it is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. It may develop from diffuse astrocytoma WHO grade II or anaplastic astrocytoma (secondary glioblastoma), but more frequently, it manifests after a short clinical history de novo, without evidence of a less malignant precursor lesion (primary glioblastoma). Two histologic variants are recognized: giant cell glioblastoma and gliosarcoma. (WHO) ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Glioblastoma","conceptCode":"C3058","definition":"The most malignant astrocytic tumor (WHO grade 4).  It is composed of poorly differentiated neoplastic astrocytes and is characterized by the presence of cellular polymorphism, nuclear atypia, brisk mitotic activity, vascular thrombosis, microvascular proliferation, and necrosis. It typically affects adults and is preferentially located in the cerebral hemispheres. (Adapted from WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5C534CC-6FFB-BB02-E040-BB89AD4314F2","latestVersionIndicator":"Yes","beginDate":"2013-02-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE60-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Liver and hepatobiliary cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"5581335","version":"1","preferredName":"Liver and Intrahepatic Bile Duct Carcinoma","longName":"5581335","preferredDefinition":"Primary liver cancer is cancer that forms in the tissues of the liver. Secondary liver cancer is cancer that spreads to the liver from another part of the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver and Intrahepatic Bile Duct Carcinoma","conceptCode":"C7927","definition":"A carcinoma that arises from the hepatocytes or intrahepatic bile ducts.  The main subtypes are hepatocellular carcinoma (hepatoma) and cholangiocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B7A2-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE61-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Hepatoblastoma","valueDescription":null,"ValueMeaning":{"publicId":"4264913","version":"1","preferredName":"Hepatoblastoma","longName":"4264913","preferredDefinition":"A malignant liver neoplasm that occurs almost exclusively in infants, although isolated cases in older children and adults have been reported. Grossly, hepatoblastoma is solid, well circumscribed, and more often solitary than multiple. Microscopically, most of the tumors are composed exclusively of immature hepatocytic elements. About a fourth of hepatoblastomas contain a stromal component that may be undifferentiated or develop into bone or cartilage. The treatment of choice for hepatoblastoma is surgical excision with adjuvant therapy. Liver transplantation is being increasingly used as well.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatoblastoma","conceptCode":"C3728","definition":"A malignant embryonal neoplasm that arises from the liver. It occurs almost exclusively in infants, although isolated cases in older children and adults have been reported. Microscopically,  it consists of either epithelial or epithelial and mesenchymal components.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67F3F28-FD89-6FE9-E040-BB89AD433764","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE62-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Laryngeal squamous cell carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"3794706","version":"1","preferredName":"Laryngeal Squamous Cell Carcinoma","longName":"3794706","preferredDefinition":"A squamous cell carcinoma arising from the larynx.  It is the most common type of laryngeal carcinoma.  The site of origin within the larynx influences the symptoms, histologic characteristics, and clinical behavior of squamous cell carcinoma.  The laryngeal squamous cell carcinomas can be glottic, supraglottic, and transglottic.  Glottic carcinoma is the most frequent form of laryngeal carcinoma in the United States.  Microscopically, squamous cell carcinomas of the larynx are similar in their appearance to squamous cell carcinomas arising elsewhere (adapted from Sternberg's Diagnostic Surgical Pathology, 3rd ed., 1999).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laryngeal Squamous Cell Carcinoma","conceptCode":"C4044","definition":"A squamous cell carcinoma that arises from the larynx.  It is the most common histologic type of laryngeal carcinoma.  It can arise from the glottis, supraglottic area, or it can be transglottic.  Glottic squamous cell carcinoma is the most frequent laryngeal carcinoma in the United States.  The symptoms, clinical behavior and the prognosis depend on the site of origin within the larynx.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E010110A-EA82-64DE-E040-BB89AD431324","latestVersionIndicator":"Yes","beginDate":"2013-06-26","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-06-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE63-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Leiomyosarcoma (excluding uterine leiomyosarcoma)","valueDescription":null,"ValueMeaning":{"publicId":"4824388","version":"1","preferredName":"Leiomyosarcoma","longName":"4824388","preferredDefinition":"An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women.  It is characterized by a proliferation of neoplastic spindle cells.  Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leiomyosarcoma","conceptCode":"C3158","definition":"An uncommon, aggressive malignant smooth muscle neoplasm, usually occurring in post-menopausal women.  It is characterized by a proliferation of neoplastic spindle cells.  Morphologic variants include epithelioid, granular cell, inflammatory and myxoid leimyosarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"15EBDE73-B344-8DA9-E050-BB89AD4368FB","latestVersionIndicator":"Yes","beginDate":"2015-05-12","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE64-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Leptomeningeal metastases, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722599","version":"1","preferredName":"Metastatic Malignant Neoplasm in the Leptomeninges","longName":"4722599","preferredDefinition":"A serious problem that may occur in cancer in which cancer cells spread from the original (primary) tumor to the meninges (thin layers of tissue that cover and protect the brain and spinal cord). It can happen in many types of cancer, but is the most common in melanoma, breast, lung, and gastrointestinal cancer. The cancer may cause the meninges to be inflamed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Malignant Neoplasm in the Leptomeninges","conceptCode":"C3814","definition":"A malignant neoplasm that has spread from its original site of growth to the leptomeninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A2532-F8B3-F227-E050-BB89AD433E96","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE65-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Lip and oral cavity squamous cell carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"3794704","version":"1","preferredName":"Lip and Oral Cavity Squamous Cell Carcinoma","longName":"3794704","preferredDefinition":"A squamous cell carcinoma arising from the lip or the oral cavity.  The oral cavity squamous cell carcinoma usually arises from the buccal mucosa, tongue, or gums.  It occurs predominantly in adults who use tobacco and alcohol and has a tendency to metastasize early to lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lip and Oral Cavity Squamous Cell Carcinoma","conceptCode":"C42690","definition":"A squamous cell carcinoma arising from the lip or the oral cavity.  The oral cavity squamous cell carcinoma usually arises from the buccal mucosa, tongue, or gums.  It occurs predominantly in adults who use tobacco and alcohol and has a tendency to metastasize early to lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E010110A-EA5C-64DE-E040-BB89AD431324","latestVersionIndicator":"Yes","beginDate":"2013-06-26","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-06-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE66-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Liposarcoma","valueDescription":null,"ValueMeaning":{"publicId":"3179354","version":"1","preferredName":"Liposarcoma","longName":"3179354","preferredDefinition":"A usually painless malignant tumor that arises from adipose tissue.  Microscopically, it may contain a spectrum of neoplastic adipocytes ranging from lipoblasts to pleomorphic malignant adipocytes.  Representative morphologic variants include: well differentiated, dedifferentiated, pleomorphic, and myxoid/round cell liposarcoma.  The metastatic potential is higher in less differentiated tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liposarcoma","conceptCode":"C3194","definition":"A usually painless malignant tumor that arises from adipose tissue.  Microscopically, it may contain a spectrum of neoplastic adipocytes ranging from lipoblasts to pleomorphic malignant adipocytes.  Morphologic variants include: well differentiated, dedifferentiated, pleomorphic, and myxoid liposarcoma.  The metastatic potential is higher in less differentiated tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9890B54F-84F7-2C65-E040-BB89AD4320B1","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE67-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Lung adenocarcinoma","valueDescription":null,"ValueMeaning":{"publicId":"3106713","version":"1","preferredName":"Lung Adenocarcinoma","longName":"3106713","preferredDefinition":"A carcinoma characterized by the presence of malignant glandular epithelial cells.  There is a male predilection with a male to female ratio of 2:1.  Usually lung adenocarcinoma is asymptomatic and is identified through screening studies or as an incidental radiologic finding.  If clinical symptoms are present they include shortness of breath, cough, hemoptysis, chest pain, and fever.  Tobacco smoke is a known risk factor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Adenocarcinoma","conceptCode":"C3512","definition":"A carcinoma that arises from the lung and is characterized by the presence of malignant glandular epithelial cells.  There is a male predilection with a male to female ratio of 2:1.  Usually lung adenocarcinoma is asymptomatic and is identified through screening studies or as an incidental radiologic finding.  If clinical symptoms are present they include shortness of breath, cough, hemoptysis, chest pain, and fever.  Tobacco smoke is a known risk factor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"883834AB-0D4B-C6A6-E040-BB89AD431A8D","latestVersionIndicator":"Yes","beginDate":"2010-06-04","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE68-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Lung cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"5581336","version":"1","preferredName":"Lung Carcinoma","longName":"5581336","preferredDefinition":"A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Carcinoma","conceptCode":"C4878","definition":"A carcinoma originating in the lung. Lung carcinomas usually arise from the epithelium that lines the bronchial tree (bronchogenic carcinomas), and are classified as small cell or non-small cell carcinomas. Non-small cell lung carcinomas are usually adenocarcinomas, squamous cell carcinomas, or large cell carcinomas. Metastatic carcinomas to the lung are also common, and can be difficult to distinguish from primary tumors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B7D0-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE69-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Squamous cell lung carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"2956083","version":"1","preferredName":"Squamous Cell Lung Carcinoma","longName":"2956083","preferredDefinition":"A carcinoma arising from malignant squamous bronchial epithelial cells and characterized by the presence of keratinization and/or intercellular bridges.  Cigarette smoking and arsenic exposure are strongly associated with squamous cell lung carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Squamous Cell Carcinoma","conceptCode":"C3493","definition":"A carcinoma arising from squamous bronchial epithelial cells. It may be keratinizing or non-keratinizing. Keratinizing squamous cell carcinoma is characterized by the presence of keratinization, pearl formation, and/or intercellular bridges. Non-keratinizing squamous cell carcinoma is characterized by the absence of keratinization, pearl formation, and intercellular bridges. Cigarette smoking and arsenic exposure are strongly associated with squamous cell lung carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76EBECE2-B835-A0E2-E040-BB89AD435984","latestVersionIndicator":"Yes","beginDate":"2009-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE6A-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Male reproductive system cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722578","version":"1","preferredName":"Malignant Male Reproductive System Neoplasm","longName":"4722578","preferredDefinition":"A primary or metastatic malignant neoplasm involving the male reproductive system.  Representative examples include prostate carcinoma, penile carcinoma, testicular seminoma, and testicular embryonal carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Male Reproductive System Neoplasm","conceptCode":"C8561","definition":"A primary or metastatic malignant neoplasm involving the male reproductive system.  Representative examples include prostate carcinoma, penile carcinoma, testicular seminoma, and testicular embryonal carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B8CA-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE6B-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Malignant ascites, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4265267","version":"1","preferredName":"Malignant Ascites","longName":"4265267","preferredDefinition":"Accumulation of fluid in the peritoneal cavity resulting from the growth of primary or metastatic malignant neoplasms in the peritoneum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Peritoneal Effusion","conceptCode":"C3815","definition":"Accumulation of fluid in the peritoneal cavity resulting from the growth of primary or metastatic malignant neoplasms in the peritoneum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4DE0-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE6C-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Malignant fibrous histiocytoma","valueDescription":null,"ValueMeaning":{"publicId":"4417403","version":"1","preferredName":"Unclassified Pleomorphic Sarcoma","longName":"4417403","preferredDefinition":"A pleomorphic sarcoma characterized by the presence of fibrohistiocytic cells and spindle cells arranged in a storiform pattern.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated Pleomorphic Sarcoma","conceptCode":"C4247","definition":"An undifferentiated soft tissue sarcoma characterized by the presence of a pleomorphic malignant cellular infiltrate.  It is also known as malignant fibrous histiocytoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF69122E-9D72-60EF-E040-BB89AD436B90","latestVersionIndicator":"Yes","beginDate":"2014-07-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE6D-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Miscellaneous neoplasm, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722607","version":"1","preferredName":"Miscellaneous Neoplasm","longName":"4722607","preferredDefinition":"A benign or malignant neoplasm which is not further characterized.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Miscellaneous Neoplasm","conceptCode":"C102883","definition":"A benign or malignant neoplasm which is not further characterized.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A2532-F9CA-F227-E050-BB89AD433E96","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE6E-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Head and neck cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722789","version":"1","preferredName":"Malignant Head and Neck Neoplasm","longName":"4722789","preferredDefinition":"A primary or metastatic malignant neoplasm affecting the head and neck.  Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Head and Neck Neoplasm","conceptCode":"C4013","definition":"A primary or metastatic malignant neoplasm affecting the head and neck.  Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-2441-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"COOPERM","dateModified":"2019-02-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE6F-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Anaplastic oligodendroglioma","valueDescription":null,"ValueMeaning":{"publicId":"2572933","version":"1","preferredName":"Anaplastic oligodendroglioma","longName":"2572933","preferredDefinition":"A WHO grade III oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Oligodendroglioma","conceptCode":"C4326","definition":"A WHO grade 3 oligodendroglioma with focal or diffuse malignant morphologic features (prominent nuclear pleomorphism, mitoses, and increased cellularity).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE70-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Malignant peripheral nerve sheath tumor","valueDescription":null,"ValueMeaning":{"publicId":"2838605","version":"1","preferredName":"Malignant Peripheral Nerve Sheath Tumor","longName":"2838605","preferredDefinition":"An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life.  It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region.  It may be associated with neurofibromatosis 1 (NF1).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Peripheral Nerve Sheath Tumor","conceptCode":"C3798","definition":"An uncommon, highly aggressive malignant tumor, arising from the peripheral nerves and affecting mostly adults in their third to sixth decades of life.  It usually occurs in medium-sized and large nerves of the buttock, thigh, upper arm, or the paraspinal region.  It may be associated with neurofibromatosis 1 (NF1).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"62A6485A-AE88-B656-E040-BB89AD437D5F","latestVersionIndicator":"Yes","beginDate":"2009-02-11","endDate":null,"createdBy":"LEEB","dateCreated":"2009-02-11","modifiedBy":"ONEDATA","dateModified":"2009-02-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE71-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Medullary thyroid carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"2861420","version":"1","preferredName":"Thyroid Gland Medullary Carcinoma","longName":"2861420","preferredDefinition":"A neuroendocrine carcinoma arising from the C-cells of the thyroid gland.  It is closely associated with multiple endocrine neoplasia syndromes.  Approximately 10% to 20% of medullary thyroid carcinomas are familial.  Patients usually present with a thyroid nodule that is painless and firm.  In the majority of cases nodal involvement is present at diagnosis.  Surgery is the preferred treatment for both primary lesions and recurrences.  This carcinoma is generally not very sensitive to radiation and almost unresponsive to chemotherapy.  - 2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Medullary Carcinoma","conceptCode":"C3879","definition":"A neuroendocrine carcinoma arising from the C-cells of the thyroid gland. It is closely associated with multiple endocrine neoplasia syndromes. Approximately 10% to 20% of medullary thyroid carcinomas are familial. Patients usually present with a thyroid nodule that is painless and firm. In the majority of cases nodal involvement is present at diagnosis. Surgery is the preferred treatment for both primary lesions and recurrences. This carcinoma is generally not very sensitive to radiation and almost unresponsive to chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"67B13250-5416-3FB8-E040-BB89AD43483F","latestVersionIndicator":"Yes","beginDate":"2009-04-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2009-04-16","modifiedBy":"ONEDATA","dateModified":"2009-04-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE72-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Mesothelioma","valueDescription":null,"ValueMeaning":{"publicId":"6156323","version":"1","preferredName":"Mesothelial Neoplasm","longName":"6156323","preferredDefinition":"A benign or malignant neoplasm arising from mesothelial cells.  Mesothelial cells are the lining cells of the pleura and peritoneum. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mesothelial Neoplasm","conceptCode":"C3786","definition":"A neoplasm characterized by the proliferation of neoplastic mesothelial cells. It usually arises from the pleura or peritoneum. This category includes malignant mesothelioma, adenomatoid tumor (benign mesothelioma), well differentiated papillary mesothelial tumor, and multicystic mesothelioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"68A3820C-EE87-5640-E053-F662850AA127","latestVersionIndicator":"Yes","beginDate":"2018-03-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-30","modifiedBy":"ONEDATA","dateModified":"2018-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE73-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Metastases to bone, NOS","valueDescription":null,"ValueMeaning":{"publicId":"2857211","version":"1","preferredName":"Metastatic Malignant Neoplasm to the Bone","longName":"2857211","preferredDefinition":"Cancer that has spread from the original (primary) tumor to the bone.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Malignant Neoplasm in the Bone","conceptCode":"C3580","definition":"The spread of a malignant neoplasm from a primary site to the skeletal system.  The majority of metastatic neoplasms to the bone are carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"661EB49B-B2D9-7D2B-E040-BB89AD4340DC","latestVersionIndicator":"Yes","beginDate":"2009-03-27","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-03-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE74-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Metastases to liver, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722601","version":"1","preferredName":"Metastatic Malignant Neoplasm in the Liver","longName":"4722601","preferredDefinition":"A malignant neoplasm that has spread to the liver from another (primary) anatomic site.  Such malignant neoplasms may be carcinomas, lymphomas, melanomas, or sarcomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Malignant Neoplasm in the Liver","conceptCode":"C4758","definition":"A malignant neoplasm that has spread to the liver from another (primary) anatomic site. Representative examples include carcinomas, lymphomas, melanomas, or sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A2532-F923-F227-E050-BB89AD433E96","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE75-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Metastases to lung, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722602","version":"1","preferredName":"Metastatic Malignant Neoplasm in the Lung","longName":"4722602","preferredDefinition":"The spread of a malignant neoplasm to the lung. This may be from a primary lung malignant neoplasm, or from a malignant neoplasm at a distant site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Malignant Neoplasm in the Lung","conceptCode":"C3577","definition":"The spread of a malignant neoplasm to the lung. This may be from a primary lung malignant neoplasm, or from a malignant neoplasm at a distant site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A2532-F946-F227-E050-BB89AD433E96","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE76-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Metastases to skin, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722605","version":"1","preferredName":"Metastatic Malignant Neoplasm in the Skin","longName":"4722605","preferredDefinition":"The spread of a malignant neoplasm to the skin.  This may be from a primary skin malignant neoplasm, or from a malignant neoplasm at a distant site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Malignant Neoplasm in the Skin","conceptCode":"C5629","definition":"The spread of a malignant neoplasm to the skin.  This may be from a primary skin malignant neoplasm, or from a malignant neoplasm at a distant site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A2532-F98F-F227-E050-BB89AD433E96","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE77-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Nasopharyngeal carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"4264956","version":"1","preferredName":"Nasopharyngeal Carcinoma","longName":"4264956","preferredDefinition":"A carcinoma arising from the nasopharyngeal epithelium.  It includes the following types: keratinizing squamous cell carcinoma, nonkeratinizing carcinoma (differentiated and undifferentiated), basaloid squamous cell carcinoma, and papillary adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nasopharyngeal Carcinoma","conceptCode":"C3871","definition":"A carcinoma arising from the nasopharyngeal epithelium.  It includes the following types: keratinizing squamous cell carcinoma, nonkeratinizing carcinoma (differentiated and undifferentiated), basaloid squamous cell carcinoma, and papillary adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3A91-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE78-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Merkel cell tumor","valueDescription":null,"ValueMeaning":{"publicId":"3210716","version":"1","preferredName":"Merkel Cell Carcinoma","longName":"3210716","preferredDefinition":"A rare malignant cutaneous tumor seen in elderly patients.  Its usual location is on the head, neck and extremities.  The tumor is composed of small round cells with scanty cytoplasm arranged in a trabecular pattern, or in ill-defined nodules or in a diffuse pattern.  The tumor cells contain cytoplasmic membrane-bound dense core granules resembling neurosecretory granules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Merkel Cell Carcinoma","conceptCode":"C9231","definition":"A rare aggressive neuroendocrine carcinoma that usually arises from the skin. Rarely, it arises from extracutaneous sites, including the oral cavity, salivary glands, breast, vulva, and vaginal wall. The tumor is composed of small round cells with scanty cytoplasm. Merkel cell polyomavirus is implicated in the majority of cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-935E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE79-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Non-small cell lung cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"3534668","version":"1","preferredName":"NSCLC","longName":"3534668","preferredDefinition":"A group of at least three distinct histological types of lung cancer, including squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.  Non-small cell lung carcinomas have a poor response to conventional chemotherapy.  --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Non-Small Cell Carcinoma","conceptCode":"C2926","definition":"A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C597D472-1BE4-C3F6-E040-BB89AD434BBD","latestVersionIndicator":"Yes","beginDate":"2012-07-24","endDate":null,"createdBy":"LEL","dateCreated":"2012-07-24","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE7A-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Adenocarcinoma of the esophagus","valueDescription":null,"ValueMeaning":{"publicId":"4722733","version":"1","preferredName":"Esophageal Adenocarcinoma","longName":"4722733","preferredDefinition":"A malignant tumor with glandular differentiation arising predominantly from Barrett mucosa in the lower third of the esophagus.  Rare examples of esophageal adenocarcinoma deriving from ectopic gastric mucosa in the upper esophagus have also been reported.  Grossly, esophageal adenocarcinomas are similar to esophageal squamous cell carcinomas.  Microscopically, adenocarcinomas arising in the setting of Barrett esophagus are typically papillary and/or tubular.  The prognosis is poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal Adenocarcinoma","conceptCode":"C4025","definition":"A malignant tumor with glandular differentiation arising predominantly from Barrett mucosa in the lower third of the esophagus.  Rare examples of esophageal adenocarcinoma deriving from ectopic gastric mucosa in the upper esophagus have also been reported.  Grossly, esophageal adenocarcinomas are similar to esophageal squamous cell carcinomas.  Microscopically, adenocarcinomas arising in the setting of Barrett esophagus are typically papillary and/or tubular.  The prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1E4D-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE7B-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Esophageal cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"5581332","version":"1","preferredName":"Esophageal Carcinoma","longName":"5581332","preferredDefinition":"A malignant epithelial tumor arising from the esophageal mucosa. Two major histologic types of esophageal carcinoma have been described: squamous cell carcinoma and adenocarcinoma. This type of cancer is associated with excessive ethanol and cigarette usage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal Carcinoma","conceptCode":"C3513","definition":"A malignant epithelial tumor arising from the esophageal mucosa. Two major histologic types of esophageal carcinoma have been described: squamous cell carcinoma and adenocarcinoma. This type of cancer is associated with excessive ethanol and cigarette usage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B739-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE7C-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Squamous cell carcinoma of the esophagus","valueDescription":null,"ValueMeaning":{"publicId":"4722729","version":"1","preferredName":"Esophageal Squamous Cell Carcinoma","longName":"4722729","preferredDefinition":"A squamous cell carcinoma arising from the esophagus.  It is associated with a long history of tobacco and alcohol abuse and is exceedingly rare before the age of 30.  The median age is around 65 in both males and females.  It is located mostly in the middle and lower third of the esophagus.  Grossly, polypoid, ulcerated, plaque-like and occult lesions have been described.  The microscopic features are the same as in other squamous cell carcinomas.  Any degree of differentiation may occur, and variation within a single tumor is common.  The prognosis is poor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Esophageal Squamous Cell Carcinoma","conceptCode":"C4024","definition":"A squamous cell carcinoma arising from the esophagus.  It is associated with a long history of tobacco and alcohol abuse and is exceedingly rare before the age of 30.  The median age is around 65 in both males and females.  It is located mostly in the middle and lower third of the esophagus.  Grossly, polypoid, ulcerated, plaque-like and occult lesions have been described.  The microscopic features are the same as in other squamous cell carcinomas.  Any degree of differentiation may occur, and variation within a single tumor is common.  The prognosis is poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1DC4-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE7D-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Oligodendroglioma, NOS","valueDescription":null,"ValueMeaning":{"publicId":"5698554","version":"1","preferredName":"Oligodendroglioma, Not Otherwise Specified","longName":"5698554","preferredDefinition":"An oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oligodendroglioma, Not Otherwise Specified","conceptCode":"C129319","definition":"A central nervous system tumor with morphological features of oligodendroglioma in which there is insufficient information on the IDH genes and 1p/19q codeletion status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A2D2B82-B1D1-2EE0-E053-F662850A413A","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2017-03-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE7E-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Osteosarcoma","valueDescription":null,"ValueMeaning":{"publicId":"5207491","version":"1","preferredName":"Stratum 3: Osteosarcoma patients","longName":"5207491","preferredDefinition":"A usually aggressive malignant bone-forming mesenchymal neoplasm, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Osteosarcoma","conceptCode":"C9145","definition":"A usually aggressive malignant bone-forming mesenchymal neoplasm, predominantly affecting adolescents and young adults. It usually involves bones and less frequently extraosseous sites. It often involves the long bones (particularly distal femur, proximal tibia, and proximal humerus). Pain with or without a palpable mass is the most frequent clinical symptom. It may spread to other anatomic sites, particularly the lungs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F599C02-BE31-4D24-E050-BB89AD436193","latestVersionIndicator":"Yes","beginDate":"2016-03-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2016-03-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE7F-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Ovarian tumors of low malignant potential","valueDescription":null,"ValueMeaning":{"publicId":"4722824","version":"1","preferredName":"Borderline Ovarian Surface Epithelial-Stromal Tumor","longName":"4722824","preferredDefinition":"An epithelial tumor arising from the ovary without definitive morphologic characteristics of malignancy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline Ovarian Epithelial Tumor","conceptCode":"C4783","definition":"A low grade epithelial tumor arising from the ovary. It is characterized by an atypical proliferation of epithelial cells. There is no evidence of stromal invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8C8F0D-8A67-02A0-E050-BB89AD430E17","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE80-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Pancreatic cancer (excluding Islets), NOS","valueDescription":null,"ValueMeaning":{"publicId":"5581339","version":"1","preferredName":"Pancreatic Carcinoma","longName":"5581339","preferredDefinition":"A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Carcinoma","conceptCode":"C3850","definition":"A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B839-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE81-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Islet cell tumors of the pancreas","valueDescription":null,"ValueMeaning":{"publicId":"3250495","version":"1","preferredName":"Pancreatic Neuroendocrine Tumor","longName":"3250495","preferredDefinition":"A low or intermediate grade well differentiated tumor with neuroendocrine differentiation that arises from the pancreas.  According to the presence or absence of clinical syndromes that result from hormone hypersecretion, pancreatic neuroendocrine tumors are classified either as functional or nonfunctional.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Neuroendocrine Tumor","conceptCode":"C27720","definition":"A well differentiated, low, intermediate, or high grade neoplasm with neuroendocrine differentiation that arises from the pancreas.  According to the presence or absence of clinical syndromes that result from hormone hypersecretion, pancreatic neuroendocrine tumors are classified either as functional or nonfunctional.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6F215E6-C657-B293-E040-BB89AD432EF3","latestVersionIndicator":"Yes","beginDate":"2011-06-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE82-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Papillary thyroid carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"4264948","version":"1","preferredName":"Thyroid Gland Papillary Carcinoma","longName":"4264948","preferredDefinition":"A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  It is linked to radiation exposure and is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries.  Diagnostic procedures include: thyroid function tests, thyroid radioisotope scanning, thyroid ultrasound, and fine needle biopsy.  Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei.  The nuclei also display clearing or have a ground glass appearance.  Depending on the size and spread of the disease, surgical options include lobectomy, and partial or complete thyroidectomy.  Adjuvant treatment options include: radioiodine therapy, TSH suppression and external radiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Papillary Carcinoma","conceptCode":"C4035","definition":"A differentiated adenocarcinoma arising from the follicular cells of the thyroid gland.  Radiation exposure is a risk factor and it is the most common malignant thyroid lesion, comprising 75% to 80% of all thyroid cancers in iodine sufficient countries.  Diagnostic procedures include thyroid ultrasound and fine needle biopsy.  Microscopically, the diagnosis is based on the distinct characteristics of the malignant cells, which include enlargement, oval shape, elongation, and overlapping of the nuclei.  The nuclei also display clearing or have a ground glass appearance.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-38ED-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE83-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Papillary renal cell carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"2581626","version":"1","preferredName":"Papillary Renal Cell Carcinoma","longName":"2581626","preferredDefinition":"Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas.  It can be hereditary or sporadic.  The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y.  The peak incidence is in the sixth and seven decades.  It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Renal Cell Carcinoma","conceptCode":"C6975","definition":"Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas.  It can be hereditary or sporadic.  The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y.  The peak incidence is in the sixth and seven decades.  It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0BE7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-07","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-07","modifiedBy":"ONEDATA","dateModified":"2006-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE84-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Parathyroid cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"3210719","version":"1","preferredName":"Parathyroid Gland Carcinoma","longName":"3210719","preferredDefinition":"A malignant tumor arising from the parenchymal cells of the parathyroid gland. It is associated with the symptoms of primary hyperparathyroidism, resulting from the excessive production of parathyroid hormone. Morphologically, the differential diagnosis from parathyroid gland adenoma may be difficult. A definitive diagnosis of carcinoma is made only in the presence of capsular invasion, vascular invasion, and/or perineural invasion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Parathyroid Gland Carcinoma","conceptCode":"C4906","definition":"A malignant tumor arising from the parenchymal cells of the parathyroid gland. It is associated with the symptoms of primary hyperparathyroidism, resulting from the excessive production of parathyroid hormone. Morphologically, the differential diagnosis from parathyroid gland adenoma may be difficult. A definitive diagnosis of carcinoma is made only in the presence of capsular invasion, vascular invasion, and/or perineural invasion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-93FA-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE85-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Penile cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722582","version":"1","preferredName":"Penile Carcinoma","longName":"4722582","preferredDefinition":"A carcinoma that arises from the penis. Risk factors include phimosis and human papillomavirus infection. The majority of penile carcinomas are squamous cell carcinomas. The most frequent clinical presentation is an irregular mass in the glans of the penis. Treatment includes surgical management and radiation therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Penile Carcinoma","conceptCode":"C9061","definition":"A carcinoma that arises from the penis. Risk factors include phimosis and human papillomavirus infection. The majority of penile carcinomas are squamous cell carcinomas. The most frequent clinical presentation is an irregular mass in the glans of the penis. Treatment includes surgical management and radiation therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B916-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE86-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Pharyngeal (including Hypopharyngeal and Oropharyngeal) squamous cell carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"3794702","version":"1","preferredName":"Pharyngeal Squamous Cell Carcinoma","longName":"3794702","preferredDefinition":"A squamous cell carcinoma that arises from the pharynx.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharyngeal Squamous Cell Carcinoma","conceptCode":"C102872","definition":"A squamous cell carcinoma that arises from the pharynx.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E010110A-EA36-64DE-E040-BB89AD431324","latestVersionIndicator":"Yes","beginDate":"2013-06-26","endDate":null,"createdBy":"SHIDED","dateCreated":"2013-06-26","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE87-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Pheochromocytoma (adrenal)","valueDescription":null,"ValueMeaning":{"publicId":"3210721","version":"1","preferredName":"Adrenal Gland Pheochromocytoma","longName":"3210721","preferredDefinition":"A benign or malignant neuroendocrine neoplasm of the sympathetic nervous system that secretes catecholamines.  It arises from the chromaffin cells of the adrenal medulla.  Clinical presentation includes headaches, palpitations, chest and abdominal pain, hypertension, fever, and tremor.  Microscopically, a characteristic nesting (zellballen) growth pattern is usually seen.  Other growth patterns including trabecular pattern may also be present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adrenal Gland Pheochromocytoma","conceptCode":"C3326","definition":"A neuroendocrine neoplasm of the sympathetic nervous system that arises from the chromaffin cells of the adrenal medulla and secretes catecholamines. Clinical presentation includes headaches, palpitations, chest and abdominal pain, hypertension, fever, and tremor.  Microscopically, a characteristic nesting (zellballen) growth pattern is usually seen.  Other growth patterns including trabecular pattern may also be present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-943E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE88-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Pituitary gland cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722742","version":"1","preferredName":"Pituitary Gland Carcinoma","longName":"4722742","preferredDefinition":"A rare adenocarcinoma with poor prognosis, arising from the adenohypophysial cells of the anterior lobe of the pituitary gland or pre-existing adenomas.  The majority are hormonally functioning neoplasms, usually producing prolactin or ACTH.  The diagnosis is based on the presence of metastases.  Syndromes associated with pituitary gland carcinomas include hyperprolactinemia, Cushing disease, and acromegaly.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Pituitary Neuroendocrine Tumor","conceptCode":"C4536","definition":"Pituitary neuroendocrine tumor that has spread from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-2098-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE89-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Prostate cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"5581340","version":"1","preferredName":"Prostate Carcinoma","longName":"5581340","preferredDefinition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.  -- 2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Carcinoma","conceptCode":"C4863","definition":"One of the most common malignant tumors afflicting men.  The majority of carcinomas arise in the peripheral zone and a minority occur in the central or the transitional zone of the prostate gland.  Grossly, prostatic carcinomas appear as ill-defined yellow areas of discoloration in the prostate gland lobes.  Adenocarcinomas represent the overwhelming majority of prostatic carcinomas.  Prostatic-specific antigen (PSA) serum test is widely used as a screening test for the early detection of prostatic carcinoma.  Treatment options include radical prostatectomy, radiation therapy, androgen ablation and cryotherapy.  Watchful waiting or surveillance alone is an option for older patients with low-grade or low-stage disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B85C-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE8A-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Adenocarcinoma of the rectum","valueDescription":null,"ValueMeaning":{"publicId":"3088062","version":"1","preferredName":"Rectal Adenocarcinoma","longName":"3088062","preferredDefinition":"An adenocarcinoma arising from the rectum.  It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease.  Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits.  According to the degree of cellular differentiation, rectal adenocarcinomas are divided into well differentiated, moderately, and poorly differentiated.  Morphologic variants include the mucinous adenocarcinoma and signet-ring adenocarcinoma.  Lymphatic or hematogenous spread can occur early in the process and lead to systemic disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rectal Adenocarcinoma","conceptCode":"C9383","definition":"An adenocarcinoma arising from the rectum.  It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease.  Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits.  According to the degree of cellular differentiation, rectal adenocarcinomas are divided into well, moderately, and poorly differentiated.  Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E18C0F-E245-9226-E040-BB89AD430EF0","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE8B-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Renal cell carcinoma, NOS","valueDescription":null,"ValueMeaning":{"publicId":"13628737","version":"1","preferredName":"Renal Cell Carcinoma, Not Otherwise Specified","longName":"13628737v1.00","preferredDefinition":"A renal cell carcinoma that cannot be classified into one of the established subtypes of renal cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Cell Carcinoma, Not Otherwise Specified","conceptCode":"C191370","definition":"A renal cell carcinoma that cannot be classified into one of the established subtypes of renal cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC5C878C-1100-0793-E053-731AD00A03A4","latestVersionIndicator":"Yes","beginDate":"2023-05-23","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-05-23","modifiedBy":"SOKKERL","dateModified":"2023-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE8C-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Kidney cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"5581334","version":"1","preferredName":"Kidney Carcinoma","longName":"5581334","preferredDefinition":"A carcinoma arising from the epithelium of the renal parenchyma or the renal pelvis.  The majority are renal cell carcinomas.  Kidney carcinomas usually affect middle aged and elderly adults.  Hematuria, abdominal pain, and a palpable mass are common symptoms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Carcinoma","conceptCode":"C9384","definition":"A carcinoma arising from the epithelium of the renal parenchyma or the renal pelvis.  The majority are renal cell carcinomas.  Kidney carcinomas usually affect middle aged and elderly adults.  Hematuria, abdominal pain, and a palpable mass are common symptoms.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B77F-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE8D-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Rhabdomyosarcoma, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4265253","version":"1","preferredName":"Rhabdomyosarcoma","longName":"4265253","preferredDefinition":"A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomical sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Rhabdomyosarcoma","conceptCode":"C3359","definition":"A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68D1573-4BB4-FC76-E040-BB89AD43431A","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE8E-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Salivary gland cancer","valueDescription":null,"ValueMeaning":{"publicId":"6832489","version":"1","preferredName":"Salivary Gland Carcinoma","longName":"6832489","preferredDefinition":"A carcinoma that arises from the major or minor salivary glands.  Representative examples include carcinoma ex pleomorphic adenoma, adenocarcinoma, adenoid cystic carcinoma, and mucoepidermoid carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Salivary Gland Carcinoma","conceptCode":"C9272","definition":"A carcinoma that arises from the major or minor salivary glands.  Representative examples include carcinoma ex pleomorphic adenoma, adenocarcinoma, adenoid cystic carcinoma, and mucoepidermoid carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E9A76BA-9A0F-69B5-E053-F662850AA843","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"LUY","dateCreated":"2019-07-26","modifiedBy":"ONEDATA","dateModified":"2019-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE8F-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Non-Rhabdomyosarcoma soft tissue sarcoma, NOS","valueDescription":null,"ValueMeaning":{"publicId":"3384698","version":"1","preferredName":"Soft Tissue Sarcoma","longName":"3384698","preferredDefinition":"A malignant mesenchymal neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Soft Tissue Sarcoma","conceptCode":"C9306","definition":"A malignant neoplasm arising from muscle tissue, adipose tissue, blood vessels, fibrous tissue, or other supportive tissues excluding the bones.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9A3DDB0-75C8-1600-E040-BB89AD432CFF","latestVersionIndicator":"Yes","beginDate":"2012-02-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE90-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Skin cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"3210712","version":"1","preferredName":"Malignant Skin Neoplasm","longName":"3210712","preferredDefinition":"A primary or metastatic tumor involving the skin. Primary malignant skin tumors most often are carcinomas (either basal cell or squamous cell carcinomas that arise from cells in the epidermis) or melanomas that arise from pigment-containing skin melanocytes. Metastatic tumors to the skin include carcinomas and lymphomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Skin Neoplasm","conceptCode":"C2920","definition":"A primary or metastatic malignant neoplasm involving the skin. Primary malignant skin neoplasms most often are carcinomas (either basal cell or squamous cell carcinomas) or melanomas. Metastatic malignant neoplasms to the skin include carcinomas and lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-928C-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE91-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Small cell carcinoma (extrapulmonary)","valueDescription":null,"ValueMeaning":{"publicId":"14599798","version":"1","preferredName":"Extrapulmonary Small Cell Neuroendocrine Carcinoma","longName":"14599798v1.00","preferredDefinition":"A small cell neuroendocrine carcinoma that arises from an anatomic site other than the lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Extrapulmonary Small Cell Neuroendocrine Carcinoma","conceptCode":"C156457","definition":"A small cell neuroendocrine carcinoma that arises from an anatomic site other than the lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A3170C5-CE27-4485-E063-731AD00A4931","latestVersionIndicator":"Yes","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE92-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Small cell lung cancer","valueDescription":null,"ValueMeaning":{"publicId":"3297699","version":"1","preferredName":"Small Cell Lung Carcinoma","longName":"3297699","preferredDefinition":"A highly aggressive subtype of lung carcinoma characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Small Cell Carcinoma","conceptCode":"C4917","definition":"A highly aggressive carcinoma with neuroendocrine differentiation arising from the lung. It is characterized by the presence of malignant small cells and necrosis. Metastatic disease is usually present at the time of diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B035F07A-837C-9251-E040-BB89AD4303FC","latestVersionIndicator":"Yes","beginDate":"2011-10-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-26","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE93-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Adenocarcinoma of the small intestine","valueDescription":null,"ValueMeaning":{"publicId":"4722799","version":"1","preferredName":"Small Intestinal Adenocarcinoma","longName":"4722799","preferredDefinition":"An adenocarcinoma that arises from the small intestine.  Histologic variants include mucinous adenocarcinoma and signet ring cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Small Intestinal Adenocarcinoma","conceptCode":"C7888","definition":"An adenocarcinoma that arises from the small intestine.  Histologic variants include mucinous adenocarcinoma and signet ring cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-253D-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE94-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Squamous cell carcinoma of the skin","valueDescription":null,"ValueMeaning":{"publicId":"4722553","version":"1","preferredName":"Skin Squamous Cell Carcinoma","longName":"4722553","preferredDefinition":"A carcinoma arising from the squamous cells of the epidermis.  Skin squamous cell carcinoma is most commonly found on sun-exposed areas.  The majority of the tumors are well-differentiated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Squamous Cell Carcinoma","conceptCode":"C4819","definition":"A carcinoma arising from the squamous cells of the epidermis.  Skin squamous cell carcinoma is most commonly found on sun-exposed areas.  The majority of the tumors are well-differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F886EE6-B5E9-DB60-E050-BB89AD4356E3","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE95-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Squamous cell carcinoma of the anus","valueDescription":null,"ValueMeaning":{"publicId":"2580870","version":"1","preferredName":"Anal Squamous Cell Carcinoma","longName":"2580870","preferredDefinition":"A squamous cell carcinoma (SCC) arising in the anal canal or the anal margin (perianal skin).  The distinction between anal canal and anal margin SCC may be difficult, as tumors often involve both areas at the time of diagnosis.  The prognosis is generally better for anal margin SCC than for anal canal SCC.  -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anal Squamous Cell Carcinoma","conceptCode":"C9161","definition":"A squamous cell carcinoma (SCC) arising from the anal canal or the anal margin (perianal skin). Human papillomavirus is detected in the majority of cases. Homosexual HIV-positive men have an increased risk of developing anal squamous cell carcinoma in comparison to the general male population. Symptoms include anal pruritus, discomfort when sitting, pain, change in bowel habit, and bleeding. The prognosis is generally better for anal margin SCC than for anal canal SCC.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-08F3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-17","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-09-17","modifiedBy":"ONEDATA","dateModified":"2006-09-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE96-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Synovial sarcoma","valueDescription":null,"ValueMeaning":{"publicId":"3251907","version":"1","preferredName":"Synovial Sarcoma","longName":"3251907","preferredDefinition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Synovial Sarcoma","conceptCode":"C3400","definition":"A malignant neoplasm characterized by the chromosomal translocation t(X;18)(p11;q11).  It can occur at any age, but mainly affects young adults, more commonly males.  Although any site can be affected, the vast majority of the cases arise in the deep soft tissues of extremities, especially around the knee.  Microscopically, synovial sarcoma is classified as monophasic (with a spindle or epithelial cell component) or biphasic (with both spindle and epithelial cell components).  Synovial sarcomas can recur or metastasize to the lungs, bones, and lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A77CE4DC-22FC-EFB7-E040-BB89AD430FFC","latestVersionIndicator":"Yes","beginDate":"2011-07-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-07-07","modifiedBy":"MAESKEB","dateModified":"2018-11-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE97-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Testicular nonseminomatous germ cell tumor, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722791","version":"1","preferredName":"Malignant Testicular Non-Seminomatous Germ Cell Tumor","longName":"4722791","preferredDefinition":"A classification of testicular cancers that arise in specialized sex cells called germ cells. Nonseminomas include embryonal carcinoma, teratoma, choriocarcinoma, and yolk sac tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Testicular Non-Seminomatous Germ Cell Tumor","conceptCode":"C5027","definition":"A classification of testicular cancers that arise in specialized sex cells called germ cells. Nonseminomas include embryonal carcinoma, teratoma, choriocarcinoma, and yolk sac tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-247B-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE98-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Testicular cancer (excluding germ cell or trophoblastic cancer)","valueDescription":null,"ValueMeaning":{"publicId":"2672904","version":"1","preferredName":"Malignant Testicular Germ Cell Tumor","longName":"2672904","preferredDefinition":"A malignant tumor predominantly affecting young men and often associated with cryptorchidism.  Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Testicular Germ Cell Tumor","conceptCode":"C9063","definition":"A malignant germ cell tumor that arises from the testis. It predominantly affects young men. Seminoma is the most frequently seen malignant testicular germ cell tumor, followed by embryonal carcinoma and yolk sac tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"37D5FE1C-A5B6-09FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-16","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE99-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Testicular seminoma","valueDescription":null,"ValueMeaning":{"publicId":"3895710","version":"1","preferredName":"Testicular Seminoma","longName":"3895710","preferredDefinition":"A malignant germ cell tumor arising from the testis.  It is believed that it is derived from the sexually undifferentiated embryonic gonad.  Treatment with radiotherapy is highly successful when the tumor is diagnosed in localized stages, which represents the majority of presentations of seminoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Testicular Seminoma","conceptCode":"C7328","definition":"A malignant germ cell tumor arising from the testis.  It is believed that it is derived from the sexually undifferentiated embryonic gonad.  Treatment with radiotherapy is highly successful when the tumor is diagnosed in localized stages, which represents the majority of presentations of seminoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6374574-94AC-5E51-E040-BB89AD431AE9","latestVersionIndicator":"Yes","beginDate":"2013-09-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-09-12","modifiedBy":"ONEDATA","dateModified":"2013-09-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE9A-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Thymoma","valueDescription":null,"ValueMeaning":{"publicId":"2579823","version":"1","preferredName":"thymoma","longName":"2579823","preferredDefinition":"A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant and probably not neoplastic. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (Stedman, 25th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thymoma","conceptCode":"C3411","definition":"A neoplasm arising from the epithelial cells of the thymus.  Although thymomas are usually encapsulated tumors, they may invade the capsule and infiltrate the surrounding tissues or even metastasize to distant anatomic sites.  The following morphologic subtypes are currently recognized: type A, type B, type AB, metaplastic, micronodular, microscopic, and sclerosing thymoma.  Thymomas type B are further subdivided into types B1, B2, and B3. Thymoma type B3 usually has the most aggressive clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-04DC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-16","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE9B-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Thyroid cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"5581344","version":"1","preferredName":"Thyroid Gland Carcinoma","longName":"5581344","preferredDefinition":"A carcinoma arising from the thyroid gland. It is usually an adenocarcinoma and includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thyroid Gland Carcinoma","conceptCode":"C4815","definition":"A carcinoma arising from the thyroid gland. It includes the following main subtypes: follicular, papillary, medullary, poorly differentiated, and anaplastic carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B8E8-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE9C-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Leiomyosarcoma of the uterus","valueDescription":null,"ValueMeaning":{"publicId":"3179382","version":"1","preferredName":"Uterine Corpus Leiomyosarcoma","longName":"3179382","preferredDefinition":"An aggressive malignant smooth muscle neoplasm, arising from the uterine corpus.  It is characterized by a proliferation of neoplastic spindle cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Leiomyosarcoma","conceptCode":"C6340","definition":"An aggressive malignant smooth muscle neoplasm, arising from the uterine corpus.  It is characterized by a proliferation of neoplastic spindle cells.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98903582-4FD7-C5EF-E040-BB89AD431B68","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-12-29","modifiedBy":"ONEDATA","dateModified":"2010-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE9D-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Vaginal cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"5581348","version":"1","preferredName":"Vaginal Carcinoma","longName":"5581348","preferredDefinition":"A carcinoma arising from the vaginal epithelium. The majority of vaginal carcinomas are squamous cell carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vaginal Carcinoma","conceptCode":"C3917","definition":"A carcinoma arising from the vaginal epithelium. The majority of vaginal carcinomas are squamous cell carcinomas.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B974-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE9E-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Vulvar cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"3210732","version":"1","preferredName":"Vulvar Carcinoma","longName":"3210732","preferredDefinition":"A carcinoma arising from the vulva.  It usually affects elderly women but has been observed in premenopausal women as well.  The most frequently seen histologic type is squamous cell carcinoma. The most common site of involvement is the labia majora.  In many cases, the development of vulvar cancer is preceded by condyloma or squamous dysplasia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vulvar Carcinoma","conceptCode":"C4866","definition":"A carcinoma arising from the vulva.  It usually affects elderly women but has been observed in premenopausal women as well.  The most frequently seen histologic type is squamous cell carcinoma. The most common site of involvement is the labia majora.  In many cases, the development of vulvar cancer is preceded by condyloma or squamous dysplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9600-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CE9F-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Endometrial stromal sarcoma","valueDescription":null,"ValueMeaning":{"publicId":"4265242","version":"1","preferredName":"Endometrioid Stromal Sarcoma","longName":"4265242","preferredDefinition":"A malignant, infiltrating mesenchymal tumor arising from the uterine corpus, cervix, vagina, and the ovary. Based on its morphologic characteristics, it is classified as either a low grade or an undifferentiated (high grade) stromal sarcoma. The low grade endometrioid stromal sarcoma is characterized by the presence of oval to spindle-shape cells that resemble the cells of the endometrial stroma, without evidence of significant atypia and pleomorphism. Numerous small vessels are also present. The undifferentiated stromal sarcoma is characterized by an aggressive clinical course, the presence of significant cellular atypia, pleomorphism, and high mitotic activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Endometrioid Stromal Sarcoma","conceptCode":"C8973","definition":"A malignant mesenchymal neoplasm that affects the uterine corpus, and rarely, the ovaries, cervix, and vagina. In the uterine corpus it is classified as low grade or high grade endometrial stromal sarcoma. In the remainder of the anatomic sites it is classified as low grade endometrioid stromal sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68C00B1-7909-6438-E040-BB89AD4373BF","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CEA0-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Hepatocellular carcinoma","valueDescription":null,"ValueMeaning":{"publicId":"2573454","version":"1","preferredName":"Hepatocellular Carcinoma","longName":"2573454","preferredDefinition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatocellular Carcinoma","conceptCode":"C3099","definition":"A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EBFB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-15","modifiedBy":"CHILLIJ","dateModified":"2007-03-27","changeDescription":"03/27/2007 - Updated with NCI Thesaurus definition (abbreviated version.)","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CEA1-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Gastrointestinal stromal tumor","valueDescription":null,"ValueMeaning":{"publicId":"4265240","version":"1","preferredName":"Gastrointestinal Stromal Tumor","longName":"4265240","preferredDefinition":"A mesenchymal neoplasm most commonly seen in the gastrointestinal tract.  Cases involving tissues outside the gastrointestinal tract have also been reported (extragastrointestinal gastrointestinal stromal tumor).  It is a specific KIT-expressing and KIT-signaling-driven mesenchymal tumor.  Until recently, surgery has been the only effective therapy for this tumor.  However, many patients still experience recurrence.  Conventional chemotherapy and radiation therapy have been of limited value.  A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal Stromal Tumor","conceptCode":"C3868","definition":"A stromal tumor most commonly seen in the gastrointestinal tract. Rare cases of solitary masses in the omentum or the mesentery have also been reported (extragastrointestinal gastrointestinal stromal tumor).  It is a tumor that differentiates along the lines of interstitial cells of Cajal.  Most cases contain KIT- or PDGFRA-activating mutations. Until recently, surgery has been the only effective therapy for this tumor.  However, many patients still experience recurrence.  Conventional chemotherapy and radiation therapy have been of limited value.  A KIT tyrosine kinase inhibitor, imatinib mesylate (also known as STI-571 or Gleevec), is now effective in the treatment of relapsed and unresectable cases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F68C00B1-78B6-6438-E040-BB89AD4373BF","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CEA2-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Metastases to peritoneum, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722603","version":"1","preferredName":"Metastatic Malignant Neoplasm in the Peritoneum","longName":"4722603","preferredDefinition":"The spread of a malignant neoplasm to the peritoneum from another primary anatomic site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Malignant Neoplasm in the Peritoneum","conceptCode":"C4583","definition":"The spread of a malignant neoplasm to the peritoneum from another primary anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A2532-F969-F227-E050-BB89AD433E96","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CEA3-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Ovarian nondysgerminomatous germ cell tumor, NOS","valueDescription":null,"ValueMeaning":{"publicId":"4722793","version":"1","preferredName":"Ovarian Nondysgerminomatous Germ Cell Tumor","longName":"4722793","preferredDefinition":"A malignant germ cell tumor other than dysgerminoma that arises from the ovary.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Non-Dysgerminomatous Germ Cell Tumor","conceptCode":"C102870","definition":"A malignant germ cell tumor other than dysgerminoma that arises from the ovary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-24A1-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CEA4-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Adenocarcinoma of the pancreas","valueDescription":null,"ValueMeaning":{"publicId":"4722723","version":"1","preferredName":"Pancreatic Adenocarcinoma","longName":"4722723","preferredDefinition":"An adenocarcinoma which arises from the exocrine pancreas.  Ductal adenocarcinoma and its variants are the most common types of pancreatic adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Adenocarcinoma","conceptCode":"C8294","definition":"An adenocarcinoma which arises from the exocrine pancreas.  Ductal adenocarcinoma and its variants are the most common types of pancreatic adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-1CF7-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CEA5-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Ovarian dysgerminoma","valueDescription":null,"ValueMeaning":{"publicId":"4722795","version":"1","preferredName":"Ovarian Dysgerminoma","longName":"4722795","preferredDefinition":"A malignant germ cell tumor arising from the ovary.  Morphologically, it is identical to seminoma and consists of a monotonous population of germ cells with abundant pale cytoplasm and uniform nuclei.  The stroma invariably contains chronic inflammatory cells, mostly T-lymphocytes. It responds to chemotherapy or radiotherapy and the prognosis relates to the tumor stage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ovarian Dysgerminoma","conceptCode":"C8106","definition":"A malignant germ cell tumor arising from the ovary.  Morphologically, it is identical to seminoma and consists of a monotonous population of germ cells with abundant pale cytoplasm and uniform nuclei.  The stroma invariably contains chronic inflammatory cells, mostly T-lymphocytes. It responds to chemotherapy or radiotherapy and the prognosis relates to the tumor stage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F8A7B21-24C7-7895-E050-BB89AD43579D","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CEA6-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Melanoma","valueDescription":null,"ValueMeaning":{"publicId":"5581342","version":"1","preferredName":"Melanoma","longName":"5581342","preferredDefinition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Melanoma","conceptCode":"C3224","definition":"A malignant, usually aggressive tumor composed of atypical, neoplastic melanocytes. Most often, melanomas arise in the skin (cutaneous melanomas) and include the following histologic subtypes: superficial spreading melanoma, nodular melanoma, acral lentiginous melanoma, and lentigo maligna melanoma. Cutaneous melanomas may arise from acquired or congenital melanocytic or dysplastic nevi. Melanomas may also arise in other anatomic sites including the gastrointestinal system, eye, urinary tract, and reproductive system. Melanomas frequently metastasize to lymph nodes, liver, lungs, and brain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42019733-B8A2-634F-E053-F662850A5A61","latestVersionIndicator":"Yes","beginDate":"2016-11-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-11-23","modifiedBy":"FINCHAMB","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CEA7-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Small intestine cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"3210728","version":"1","preferredName":"Small Intestinal Carcinoma","longName":"3210728","preferredDefinition":"A carcinoma arising from the small intestine. The vast majority are adenocarcinomas. The remaining cases are adenosquamous, squamous, or undifferentiated carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Small Intestinal Carcinoma","conceptCode":"C7724","definition":"A carcinoma arising from the small intestine. The vast majority are adenocarcinomas. The remaining cases are adenosquamous, squamous, or undifferentiated carcinomas.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9552-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A3170C5-CEA8-4485-E063-731AD00A4931","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Anaplastic astrocytoma","valueDescription":null,"ValueMeaning":{"publicId":"2572930","version":"1","preferredName":"Anaplastic astrocytoma","longName":"2572930","preferredDefinition":"A diffusely infiltrating, WHO grade III astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anaplastic Astrocytoma","conceptCode":"C9477","definition":"A diffusely infiltrating, WHO grade 3 astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E9EF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-03","endDate":null,"createdBy":"MAESKEB","dateCreated":"2005-02-03","modifiedBy":"COOPERM","dateModified":"2017-03-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A34EF63-76AC-0CDB-E063-731AD00A748F","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"High-grade astrocytoma, NOS","valueDescription":null,"ValueMeaning":{"publicId":"14603356","version":"1","preferredName":"Not Otherwise Specified Anaplastic Astrocytoma","longName":"14603356v1.00","preferredDefinition":"Not characterized in any other way._A diffusely infiltrating, WHO grade 3 astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Anaplastic Astrocytoma","conceptCode":"C9477","definition":"A diffusely infiltrating, WHO grade 3 astrocytoma with focal or dispersed anaplasia, and a marked proliferative potential. It may arise from a low-grade astrocytoma, but it can also be diagnosed at first biopsy, without indication of a less malignant precursor lesion. It has an intrinsic tendency for malignant progression to glioblastoma. (WHO)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A34EF63-76AB-0CDB-E063-731AD00A748F","latestVersionIndicator":"Yes","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A34EF63-76AD-0CDB-E063-731AD00A748F","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Urothelial tract/bladder cancer, NOS","valueDescription":null,"ValueMeaning":{"publicId":"3704613","version":"1","preferredName":"Not Otherwise Specified Urothelial Carcinoma","longName":"3704613","preferredDefinition":"Not characterized in any other way.: A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis).  It is frequently papillary. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Urothelial Carcinoma","conceptCode":"C4030","definition":"A carcinoma arising from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D902E31D-3A0B-5153-E040-BB89AD437E3A","latestVersionIndicator":"Yes","beginDate":"2013-03-28","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-03-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A34EF63-76AE-0CDB-E063-731AD00A748F","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"},{"value":"Transitional cell carcinoma of the urothelial tract","valueDescription":null,"ValueMeaning":{"publicId":"3155848","version":"1","preferredName":"Urothelial Carcinoma","longName":"3155848","preferredDefinition":"A malignant neoplasm derived from the transitional epithelium of the urinary tract (urinary bladder, ureter, urethra, or renal pelvis).  It is frequently papillary. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Urothelial Carcinoma","conceptCode":"C4030","definition":"A carcinoma arising from the urothelial lining of the urinary tract (bladder, renal pelvis, ureter, or urethra).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"943B8AF5-84AC-8068-E040-BB89AD437602","latestVersionIndicator":"Yes","beginDate":"2010-11-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-11-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0A34EF63-76AF-0CDB-E063-731AD00A748F","beginDate":"2023-11-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-11-15","modifiedBy":"KUMMEROA","dateModified":"2023-11-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3377234","version":"1","preferredName":"Disease or Disorder Name","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:The words or language units by which a thing is known.","longName":"C2991:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8A2B5C7-87BF-F5C5-E040-BB89AD430636","latestVersionIndicator":"Yes","beginDate":"2012-02-10","endDate":null,"createdBy":"NYCHM","dateCreated":"2012-02-10","modifiedBy":"ONEDATA","dateModified":"2012-02-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NRG CRF:NRG Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"092D76EB-FD7A-1333-E063-731AD00A988A","latestVersionIndicator":"Yes","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"TYRRELLM","dateModified":"2024-01-31","changeDescription":null,"administrativeNotes":"2023.11.15 Many PVs added per ticket request CADSR0003071. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"What was the name of the disease?","url":null,"context":"NRG"},{"name":"NRG Text1","type":"Alternate Question Text","description":"Disease Description:","url":null,"context":"NRG"},{"name":"NRG Text 2","type":"Alternate Question Text","description":"Patient's solid tumor type","url":null,"context":"NRG"}],"origin":"NRG CRF:NRG Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"092EE515-B806-6442-E063-731AD00A6BDA","latestVersionIndicator":"Yes","beginDate":"2023-11-02","endDate":null,"createdBy":"TYRRELLM","dateCreated":"2023-11-02","modifiedBy":"GDEEN","dateModified":"2024-01-10","changeDescription":null,"administrativeNotes":"2023.11.15 AQT added per ticket request CADSR0003071. ak 11.02.2023 Added new CDE per request ticket CADSR0003022_mmt","unresolvedIssues":null,"deletedIndicator":"No"}}